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ABSTRACT
The chronic ﬁbrosing interstitial pneumonias (CFIPs) are diseases which cause 
progressive and often fatal progressive scarring of the lungs. The recent discovery of 
the ﬁrst eective pharmacological therapies for this condition have increased interest 
in the monitoring of this disease. 
Due to the complex appearance of the CFIPs on computed tomography, visual 
quantiﬁcation of disease severity and extent is limited. 
The purpose of this thesis was to develop and test a computer algorithm for the 
automated quantiﬁcation of pulmonary ﬁbrosis on CT using textural measures 
known as Minkowski functionals. 
A computer algorithm was successfully developed and this thesis presents initial 
results of testing the algorithm on a series of normal scans and on 24 prospectively 
recruited patients who also underwent a series of other tests including pulmonary 
function tests and a patient reported symptom questionnaire. The computer output 
was also compared with the visual assessment of two radiologists. 
Signiﬁcant correlations were found between computer calculated lung volume and 
total lung capacity as measured on pulmonary function tests. We also found a 
signiﬁcant correlation between computer calculated ﬁbrosis volume and both gas 
transfer and forced vital capacity. The radiologists’ visual assessment of ﬁbrosis and 
the computer estimated ﬁbrosis volume were highly correlated. 
The novel computer algorithm represents a promising method for quantifying 
pulmonary ﬁbrosis on CT with potential roles in monitoring disease progression and 
eects of therapeutic interventions. 
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CHAPTER 1: BACKGROUND
1.1 INTRODUCTION
The idiopathic interstitial pneumonias (IIPs) are a diverse group of diseases that are 
united in their ability to cause progressive ﬁbrosis or scarring in the lungs, often 
leading to severe morbidity and ultimately death. The most important of the 
idiopathic pneumonias in terms of prevalence, morbidity and mortality is the clinical 
syndrome of idiopathic pulmonary ﬁbrosis (IPF). Typically striking in the 6th to 7th 
decades, the disease causes dry cough and progressive breathlessness and has a 
median survival of only 3 years (Gribbin et al., 2006). Unfortunately there are many 
unknown quantities in this disease including the aetiology, the reason that some 
patients progress much faster than others and the lack of precision in measuring 
disease severity. This thesis will focus on one particular aspect of this disease, namely 
the need to precisely measure disease severity on computed tomography (CT). We will 
describe the development and testing of a novel computer algorithm designed to 
quantify disease severity on CT and compare it with the current clinical practice of a 
radiologist reading the scans. We will also compare the computer quantiﬁcation with 
other measures of severity including pulmonary function tests (PFTs) and patient 
reported symptoms.
This ﬁrst section of this introductory chapter will describe the current understanding 
of disease classiﬁcation, clinical phenotypes, epidemiology, theories of aetiology, 
treatment and prognosis of the IIPs, focusing mainly on the clinico-pathological 
entity of idiopathic pulmonary ﬁbrosis/usual interstitial pneumonia (IPF/UIP). The 
next section will examine the role of radiology in the assessment of IPF and the need 
to progress beyond a visual assessment of disease extent. We will also discuss non-
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radiological methods of assessing disease severity and describe some of the pros and 
cons of the dierent methods. 
1.2  THE IDIOPATHIC INTERSTITIAL PNEUMONIAS
1.2.1 Deﬁnition of the idiopathic interstitial pneumonias
The idiopathic interstitial pneumonias (IIPs) are a complex and heterogeneous 
collection of pathological conditions that cause signiﬁcant morbidity and mortality. In 
2002, the ATS/ERS international multidisciplinary consensus classiﬁcation of 
idiopathic interstitial pneumonias was published, redeﬁning the histological, clinical 
and radiological diagnosis of the IIPs (European and Society, 2002). In 2013 an update  
to the guidelines was issued which the authors speciﬁed should be treated as a 
supplement to the 2002 guidelines rather than as a ‘stand-alone’ document. This 
update introduced a number of alterations to the 2002 guidelines including the 
removal of the term ‘cryptogenic ﬁbrosing alveolitis’, acceptance of idiopathic non-
speciﬁc interstitial pneumonia (NSIP) as a distinct clinico-pathological entity and the 
use of the term ‘chronic ﬁbrosing interstitial pneumonia’ (CFIP) to describe both 
idiopathic pulmonary ﬁbrosis and idiopathic nonspeciﬁc interstitial pneumonia. 
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Table 1-1 The 2013 updated ATS/ERS classiﬁcation of idiopathic interstitial pneumonias. 
Reprinted with permission of the American Thoracic Society. Copyright © 2014 American 
Thoracic Society
The most common IIP is the clinical entity of idiopathic pulmonary ﬁbrosis (IPF), 
which corresponds to the histological pattern described as Usual Interstitial 
Pneumonia (UIP). The distinction between subtypes of IIP is important because of the 
dierences in prognosis associated with dierent histological patterns amongst 
patient cohorts (Mapel et al., 1998, Hubbard et al., 1998, Flaherty et al., 2002), with 
UIP having a signiﬁcantly worse prognosis than most of the other IIPS. For the 
purpose of this thesis, we will not be discussing conditions such as desquamative 
interstitial pneumonia and hypersensitivity pneumonitis but will be conﬁning our 
studies to patients with idiopathic disease. 
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1.2.2 Incidence/Prevalence
Estimating the incidence and prevalence of IPF is hampered by the fact that there is 
no readily available and speciﬁc test for the disease. However, available data from 
death certiﬁcation and GP diagnostic databases suggest an incidence of between 4.6 
(Gribbin et al., 2006) and 7.4 (Navaratnam et al., 2011) per 100,000 person years. 
This equates to approximately 5000 new diagnoses per year and is higher than the 
incidence of several cancers including thyroid cancer and lymphoma (Cancer 
Research UK, UK Cancer Incidence (2010) by Country Summary, April 2013). 
It has been suggested that the incidence of IPF has increased over the last few 
decades (Navaratnam et al., 2011) but no speciﬁc reason for this has been identiﬁed. 
It may partly be explained by the increased use of CT scanning which is able to pick 
up early-stage disease. In addition, the introduction of a non-invasive test (CT) when 
the previous deﬁnitive test has been invasive and restricted to patients ﬁt enough for 
surgery (open lung biopsy) is likely to lead to an increase in diagnosis. The 
endorsement of CT as a diagnostic test for IPF by professional societies is also likely 
to be a factor (Raghu et al., 2011). 
1.2.3 Mortality
Studies of mortality in IPF have shown a median survival of between 3 and 4 years 
(Gribbin et al., 2006, Mapel et al., 1998, Hubbard et al., 1998). It should be noted that 
there is a higher median survival in incident cases than prevalent cases. This is due to 
survival bias, meaning that incident cases are representative of the whole spectrum of 
disease severity, whereas patients with aggressive disease who die quickly will be 
under-represented in the prevalence group. Because of this, it has been suggested 
that studies into prognostic variables in IPF are restricted to incident cases, although 
this is not always practical (Hubbard et al., 1998).
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Unsurprisingly, mortality from IPF is increased in older age groups (Navaratnam et al., 
2011). This may be due to co-morbidities in older patients, but may also reﬂect the 
fact that younger patients diagnosed with IPF are more likely to be aected by less 
aggressive histological forms of disease such as NSIP or connective tissue disease-
associated pulmonary ﬁbrosis. 
1.2.4 Age and sex distribution
A British Thoracic Society study of 588 newly presenting patients found a median age 
at diagnosis of 67 years and a male:female ratio of 1.7:1 (Johnston et al., 1997). Other 
studies have suggested an earlier age at diagnosis but have been from specialist 
centres where younger patients with more aggressive disease are likely to be over-
represented. Some authors have suggested that IPF is, in fact, a degenerative disease 
associated with ageing. This theory is supported by the ﬁnding of shortened 
telomeres in patients with familial pulmonary ﬁbrosis and non-familial cases. 
Telomeres are non-coding  areas of DNA nucleotide repeats found at the end of 
chromosomes which protect the chromosome during cell division. Each time a cell 
divides, chromosome replication occurs and a small amount of DNA is lost from the 
end of each chromosome. Loss of a small part of the non-coding telomere DNA from 
the end of the chromosome means that important coding DNA is not lost (Cowell, 
2001). Telomere shortening is also thought to occur as a result of oxidative stress 
(Von Zglinicki, 2002). Telomeres were discovered by Elizabeth Blackburn in the 1970s 
(Blackburn and Gall, 1978) but it was only in the 2000s that the link with ageing was 
established and roles in the pathogenesis of multiple cancers and age-related 
diseases were proposed (Blasco, 2005, Brouilette et al., 2007, Torella et al., 2004, Ito 
and Barnes, 2009). A crucial factor in the maintenance of telomeres is the enzyme 
telomerase which is a ribonucleoprotein enzyme that catalyses the addition of 
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hexameric (6-base length) nucleotide repeats to the ends of chromosomes. This 
enzyme consists of 6 components - 3 pairs of each of the following molecules: 
telomerase reverse transcriptase (TERT), telomerase RNA (TERC) and dyskerin (DKC1). 
In 2007 two groups published evidence of mutations in the genes encoding 
telomerase in cases of familial pulmonary ﬁbrosis (Tsakiri et al., 2007, Armanios et 
al., 2007). Tsakiri et al also found a mutation in one patient with no family history 
(Tsakiri et al., 2007). Following this, Cronkhite el al (Cronkhite et al., 2008) studied a 
cohort of patients with familial IPF and a cohort of patients with sporadic IPF but who 
did not have speciﬁc mutations of TERC or TERT genes. They found that even patients 
without a speciﬁc genetic mutation had shorter telomeres than a control group 
without IPF. They found that 14 of 59 patients (24%) with familial IPF had telomeres 
below the 10th percentile prediction line and 17 of 73 patients (23%) with non-
familial IPF had telomeres in the bottom 10th centile. This was statistically signiﬁcant 
in both familial (p = 8.0 x 10 -6) and non-familial (p = 2.6 x 10-6) cases. The fact that 
the prevalence of IPF increases signiﬁcantly with age also lends weight to the fact that 
telomere shortening may be an important co-factor in the aetiology of the disease. 
Copley et al studied CT scans of two groups of asymptomatic patients who were 
undergoing a CT of the abdomen or a CT of the head and did not have any history of 
respiratory disease. The ﬁrst group consisted of 40 patients aged over 75 years 
(mean age 80.6 years) and the second group comprised 16 patients aged less than 55 
(mean age 39.4 years). An extensive list of exclusion factors was designed to ensure 
that patients were unlikely to have a latent undiagnosed respiratory disease. This 
prospective study consented patients to undergo thin-slice prone inspiratory high-
resolution CT. Two radiologists scored the CT scans for the presence and extent of 
reticular abnormality, cysts, bronchial dilatation, bronchial thickening, ground glass 
opacity, interlobular septal thickening and centrilobular emphysema. They found that 
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60% of the older group had a limited, predominantly subpleural, basal reticular 
pattern which was not seen in any of the younger group. Cysts were also seen in 25% 
of the older group but none of the younger group. The authors noted that the 
reticular pattern was not associated with traction bronchial dilatation, one of the 
main features of IIP. They concluded that a limited subpleural basal reticular ﬁnding 
may be a normal ﬁnding in older age groups and should not necessarily be 
interpreted as interstitial lung disease. Limitations of this study included the fact that 
the majority of patients were city dwellers and therefore there may be environmental  
factors which limit extrapolation to a non-urban population. Another limitation was 
that some subjects were ex-smokers. Perhaps the most signiﬁcant limitation is the 
lack of histological conﬁrmation, since biopsy could not be justiﬁed in this 
population. 
1.2.5 Risk factors for idiopathic pulmonary ﬁbrosis
No deﬁnitive cause for idiopathic pulmonary ﬁbrosis has been identiﬁed but a 
number of risk factors have been described. The most powerful association is with 
smoking (odds ratio 2.9) (Iwai et al., 1994) but weaker associations have also been 
shown with exposure to metallic dusts and wood dust. Farming, raising birds, 
working with stone and exposure to animal dust have also been associated with IPF 
(Baumgartner et al., 1997). Another suggested aetiology is chronic viral infection with 
the largest amount of evidence for EBV and hepatitis C. Both DNA and protein from 
EBV have been detected in greater numbers of lung biopsies from patients with IPF 
compared to the general population (Egan et al., 1995, Stewart et al., 1999). However, 
deﬁnitive conclusions are hampered by the high prevalence of EBV in the normal 
population and by the fact that many patients with IPF have received 
immunosuppression at some point, which is likely to increase the incidence of EBV. 
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Evidence for the role of hepatitis C is also mixed. Ueda et al (Ueda et al., 1992) found 
that 19 of a group of 66 patients with IPF (28.8%) tested positive to hepatitis C 
compared with 3.7% of a control group whilst Meliconi et al  (Meliconi et al., 1996) 
found a 13.3% prevalence of hepatitis C in 60 Italian patients with IPF compared with a 
0.3% prevalence in a large control group of blood donors. However, they did not ﬁnd a 
signiﬁcant dierence in prevalence amongst patients with IPF compared with a group 
with other mixed lung diseases (6.1%). Other implicated viruses are herpes viruses 7 
and 8 and cytomegalovirus (Yonemaru et al., 1997). Several other medical conditions 
have been associated with IPF, including gastro-oesophageal reﬂux and diabetes 
mellitus (Tobin et al., 1998, Gribbin et al., 2009) but a causative relationship has not 
been proven. 
1.2.6 Histology
The histological hallmark of IPF is a usual interstitial pneumonia (UIP) pattern of 
ﬁbrosis. UIP is characterised by subpleural and paraseptal ﬁbrosis and 
honeycombing, interspersed with areas of less severely aected or normal lung 
(spatial heterogeneity). There is a lack of transition zone between normal and 
aected lungs, in other words an abrupt change from normal to abnormal lung. 
Honeycombing consists of cystic, ﬁbrotic airspaces with a bronchiolar epithelial 
lining. The honeycomb cysts may contain inﬂammatory cells and mucin. Within the 
abnormal lung are ﬁbroblastic foci which reﬂect active ﬁbrosis and suggest temporal 
heterogeneity (Figure 1-1). There is hyperplasia of type II pneumocytes and there 
may be a mild lymphocytic inﬁltrate, but this should not be a prominent feature. 
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Figure 1-1 Surgical lung biopsy demonstrating UIP pattern. (A) Scanning power microscopy 
showing patchy process with honeycomb spaces (thick arrow), some preserved lung tissue 
regions (thin arrow), and ﬁbrosis extending into the lung from the subpleural regions. (B) 
Adjacent to the regions of more chronic ﬁbrosis (thick arrow) is a ﬁbroblastic focus (asterisk), 
recognised by its convex shape and composition of oedematous ﬁbroblastic tissue, suggestive 
of recent lung injury. Reproduced with permission from (Raghu et al., 2011)
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1.2.7 Potential mechanisms of disease causation
Two main mechanisms have been proposed for the development and progression of 
IPF, namely the inﬂammatory pathway and the epithelial pathway (King Jr et al., 2011). 
Initial theories centred on the contribution of inﬂammatory mechanisms and 
demonstration of an increased population of lymphocytic cells in the broncho-
alveolar lavage ﬂuid of patients with IPF. Despite this, anti-inﬂammatory medication, 
including steroids, have shown consistently poor results in patients with IPF, leading 
investigators to question the role of inﬂammation in the disease. The epithelial 
pathway focuses on the role of epithelial-dependent activation of ﬁbroblasts, which 
then leads to ﬁbrosis. This is illustrated in Figure 1-2 below:
Figure 1-2 Schematic showing the potential causative mechanisms of pulmonary ﬁbrosis in 
IPF. Reproduced with permission from (King Jr et al., 2011)
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1.3  ROLE OF RADIOLOGY IN THE ASSESSMENT OF IPF
1.3.1 Role of the chest x-ray
The ﬁrst imaging investigation in most patients with suspected lung disease is a 
chest x-ray and the majority of patients with IPF will have an abnormal chest 
radiograph at diagnosis. The classical appearance of IPF on chest x-ray is of 
peripheral reticulation, which is worse at the lung bases and often causes ill-
deﬁnition of the heart borders. The advantages of chest x-ray are that it is 
inexpensive, readily available and has a relatively low radiation burden (typical dose 
equivalent to 2.4 days background radiation) (Hall, 2002). The disadvantages of chest 
x-ray are that technical factors such as degree of inspiration and obesity may limit 
interpretation, that early disease may be missed and that ﬁndings in interstitial lung 
disease are often non-speciﬁc. For example, in a study of 118 patients with diuse 
interstitial lung disease where radiologists were asked to specify their ﬁrst choice 
diagnosis and level of conﬁdence in that diagnosis, chest x-ray was accurate in only 
57% of cases compared to an accuracy of 76% for CT. Therefore, before the advent of 
HRCT, open lung biopsy was often recommended for deﬁnitive diagnosis (Mathieson 
et al., 1989). Nevertheless, chest x-ray remains the ﬁrst imaging test in most 
patients, is often performed at routine clinic appointments to look for disease 
progression and is usually the ﬁrst line investigation when patients present acutely 
with an exacerbation of disease. 
1.3.2. Role of computed tomography
CT has a number of roles in the assessment of patients with suspected or known 
interstitial lung disease including: diagnosis, assessment of severity, follow-up and 
prediction of prognosis. 
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The typical HRCT ﬁndings of interstitial pulmonary ﬁbrosis are of peripheral, 
subpleural reticulation and honeycombing. The widely accepted Fleischner Society 
guidelines deﬁne reticulation as ‘a collection of innumerable small linear opacities 
that, by summation, produce an appearance resembling a net’. On CT imaging, 
reticulations are typically peripheral/subpleural and are usually composed of 
thickened interlobular and intralobular septa (Hansell et al., 2008) (Figure 1-3b). 
Honeycombing is deﬁned as ‘clustered cystic airspaces, typically of comparable 
diameters on the order of 3-10 mm’ (Hansell et al., 2008). It is usually subpleural and 
characterised by well-deﬁned walls and is considered to be a feature of established 
ﬁbrosis and to be irreversible (ﬁgure 1-3a).
a cb
Figure 1-3 Selected axial CT images showing a) honeycombing b) reticulation and c) traction 
bronchial dilatation
Traction bronchiectasis or traction bronchiolectasis is another feature that is 
commonly seen on HRCT and is deﬁned as ‘irregular bronchial or bronchiolar 
dilatation caused by surrounding retractile pulmonary ﬁbrosis’ (Hansell et al., 2008). 
Dilated airways normally appear as tubular, air-ﬁlled structures that do not taper in 
the same way as normal airways but may appear as cysts or microcysts at the 
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periphery of the lung, in which case they may be dicult to distinguish from 
honeycombing (Figure 1-3c).
Traditionally, open lung biopsy has been considered to be the gold standard for 
diagnosis of IIP. Unfortunately, many patients with suspected ILD are elderly with 
frequent co-morbidities and surgical risk factors that may preclude open biopsy. In 
addition, patients often present with relatively severe disease which many make them 
unsuitable for surgical biopsy. With this in mind, the sensitivity and speciﬁcity of CT 
for diagnosis has been explored. Several studies have indicated that HRCT has a high 
sensitivity and speciﬁcity for diagnosis of IPF with a positive predictive value of 
between 90 and 100% (Mathieson et al., 1989, Hunninghake et al., 2001, Raghu et al., 
1999, Grenier et al., 1991, Lee et al., 1994). As a result, several guidelines now 
recommend that if the CT appearances are typical of UIP, biopsy is not required to 
make a diagnosis (Raghu et al., 2011, Wells, 2013). Criteria for a typical/probable UIP 
pattern on CT and are described by Raghu et al in the 2011 ATS statement (Raghu et 
al., 2011) and are shown in the table below (table 1-2). It should be noted that all four 
features (subpleural basal predominance, reticular abnormality, honeycombing and 
absence of features inconsistent with UIP) should be present in order to make a 
conﬁdent CT diagnosis of UIP.
Table 1-2 High-resolution computed tomography criteria for a diagnosis of UIP. Reproduced 
with permission from (Raghu et al., 2011)
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Fell et al recently studied the predictive power of several clinical, physiological and CT 
variables for diagnosis of IPF (Fell et al., 2010). They studied 97 patients with biopsy 
proven IPF and 38 patients with other IIPs and speciﬁcally excluded patients with 
honeycombing on CT. Clinical variables included age, sex, smoking status, 
pulmonary function tests (FVC and DLCO) and 6-minute walk test (distance walked 
and whether or not the patient desaturated to <88%). CT scans were analysed by 2 
experienced radiologists using a semi-quantitative method which assesses the 
percentage of lung with ground glass change (alveolar score) and the degree of 
interstitial changes (reticulation or honeycombing) and was previously described by 
Kazerooni et al (Kazerooni et al., 1997). Using a multiple logistic regression approach, 
they found that the two most powerful predictors of IPF on biopsy were age and 
extent of ﬁbrosis on CT. Even without honeycombing they found that they could 
conﬁdently predict a biopsy diagnosis of IPF based on age and degree of ﬁbrosis on 
CT. For example, they found that for patients aged 55 and over with relatively minor 
ﬁbrosis on CT, there was a positive predictive value of 100% for IPF at surgical biopsy. 
A grading system was proposed which integrated the patient’s age and extent of CT 
ﬁbrosis in order to predict the positive predictive value for IPF on biopsy. The grading 
formula is as follows: (0.084 x age + 2.346 x HRCT interstitial score) - 3.31/5.856.
1.3.3 Role of CT in assessing IPF prognosis
Flaherty et al examined the prognostic implication of a radiological diagnosis of UIP 
compared with a radiological diagnosis of NSIP. The study group comprised 76 
patients with a histological diagnosis of UIP and 23 patients with a histological 
diagnosis of NSIP. Two radiologists read the scans and assigned them to one of three 
categories: ‘deﬁnite/probable UIP’; ‘deﬁnite/probable NSIP’ or ‘indeterminate’. 
Analysis of survival curves showed that there were signiﬁcant dierences in the 
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survival of the three categories, with the poorest survival seen in ‘deﬁnite/probable 
UIP’ and the best survival in ‘deﬁnite/probable NSIP’ (Flaherty et al., 2003a). The 
extent of ﬁbrosis on CT as judged by a semi-quantitative scoring system has also 
been shown to be a powerful predictor of prognosis (Lynch et al., 2005).
1.3.4 Role of CT in quantiﬁcation of pulmonary ﬁbrosis
A number of approaches have been applied to the quantiﬁcation of pulmonary 
ﬁbrosis on HRCT. The most basic, but probably the most widely used in clinical 
practice, is simply to describe the disease as mild, moderate or severe. There are no 
speciﬁc deﬁnitions of these severity categories so the reporting radiologist will 
typically describe the disease severity in relation to other cases they have seen in the 
past and one reader’s ‘mild’ may be another reader’s ‘moderate’. With this in mind, a 
number of attempts have been made to develop a more quantitative and reproducible 
approach to the visual estimation of disease severity. 
Goh et al, in a study of 215 patients with systemic sclerosis referred to the Royal 
Brompton Hospital (UK), performed visual scoring at 5 deﬁned anatomical levels on 
the HRCT scan (Goh et al., 2008). They ﬁrstly calculated a global extent score by 
estimating the amount of lung aected by interstitial lung disease on each slice to the 
nearest 5% and averaging this score over the 5 slices. They then assessed ‘coarseness 
of reticulation’ using a 3 point score as follows: ground glass (grade 1); microcystic 
honeycombing (air spaces less than or equal to 4 mm in diameter – grade 2); 
macrocystic honeycombing (airspaces greater than 4 mm in diameter – grade 3). The 
total ‘coarseness score’ was calculated by summating the score at each level for a 
total score of 0 to 15. They also introduced a multiplier whereby if the HRCT was 
completely normal on one section, they adjusted the score by multiplying by 5/4, 
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although this approach may lead to over-estimation of disease severity in patients 
with milder disease. 
Edey et al, also working with the Brompton Hospital group, used a similar method to 
calculate disease severity in idiopathic pulmonary ﬁbrosis (Edey et al., 2011). They 
calculated the global severity score in the same way as Goh et al although they 
analysed 6 sections per patient and assessed 5 features. The features analysed were: 
ground glass opaciﬁcation, ﬁne reticulation, coarse reticulation, microcystic and 
macrocystic honeycombing (lumped together), and consolidation. The ﬁnal scores for 
each pattern were calculated as a percentage of abnormal lung then summed and a 
mean overall score for the 6 levels was calculated. They also gave a binary score for 
emphysema at each level (0 – present, 1 – absent) and produced a total score for each 
patient (0 to 6). Traction bronchiectasis was assessed in each section for each 
parenchymal pattern (i.e. ﬁne reticulation, coarse reticulation etc.) according to a 3 
point score: 0 = none, 1 = mild, 2 = moderate or 3 = severe/striking. A so-called 
summed traction bronchiectasis score was calculated for each parenchymal pattern 
over the 6 sections. A discrepancy between the two radiologist observers was deﬁned 
as a > 15% dierence in global disease scores, more than 1 grade dierence in 
traction bronchiectasis scores and disagreement of whether or not bronchiectasis or 
emphysema were present. These were said to be resolved by consensus evaluation 
although details of the process to obtain consensus were not given in the paper. 
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1.4 COMPUTERISED METHODS FOR QUANTIFICATION OF PULMONARY FIBROSIS ON 
CT
1.4.1 The need for computerised methods
There are several disadvantages to the visual assessment of pulmonary ﬁbrosis 
including lack of precision, inter/intra-observer variation and the tedious and time-
consuming nature of the task. The computerised analysis of pulmonary ﬁbrosis oers 
a potential solution to these problems. The next section of this introduction details 
the main steps of this process and some of the dierent approaches to lung analysis. 
1.4.2 Computerised segmentation of the lungs
A prerequisite to quantitative analysis of the lung parenchyma is to separate the lung 
from the surrounding structures of the chest wall, since subsequent analysis needs to 
be applied to lung tissue only. A number of approaches to this have been developed. 
The most simplistic is termed ‘thresholding’. In this technique, a density (Hounsﬁeld 
Unit - HU) threshold is identiﬁed which is chosen to distinguish between lung tissue 
and other tissues of the chest wall and mediastinum. Since lung typically has 
Hounsﬁeld Units values in the range -1000 HU to -500 HU and soft tissues typically 
have values greater than -50 HU, a threshold of approximately -200 HU eectively 
separates normal lung from adjacent soft tissue. This method also eectively 
segments emphysematous lungs from the chest wall since this disease typically 
lowers lung density. On the other hand, ﬁbrotic or consolidated lung may have values 
of up to +100 HU and therefore segmentation of abnormal lung from adjacent soft 
tissue is problematic. Several approaches to overcoming this problem have been 
developed, all of which have advantages and disadvantages and include ‘snake’, 
‘rolling-ball’ and region-growing algorithms. Other authors such as Hu et al (Hu et 
al., 2001) have developed algorithms which use a combination of methods such as 
adaptive thresholding, region-growing and void ﬁlling. The adaptive thresholding 
method selects a density threshold which is determined by the individual scan and 
can therefore be varied according to dierences in scan technique, patient and 
disease characteristics. 
1.4.3 Automated quantiﬁcation of lung density
Once the lungs have been segmented from the chest wall, it is then possible to 
analyse the characteristics of the lung parenchyma. One of the most simple 
quantitative metrics is the mean lung density (MLD), whereby the Hounsﬁeld Unit 
value for each voxel of lung tissue is added together and divided by the total number 
of voxels. This approach is used in the analysis of emphysema, where diseased lung 
typically has lower density than normal lung (Müller et al., 1988). A number of other 
density measures have been used, such as the percentage of lung tissue below a 
deﬁned density threshold. Commonly used thresholds for assessment of emphysema 
range between -950 and -900 HU (Coxson et al., 2013, Müller et al., 1988, Coxson, 
2013).
Multiple studies have shown good correlation between quantitative emphysema 
indices, pulmonary function tests and patient reported symptoms and it has also 
been shown that MLD is increased in idiopathic pulmonary ﬁbrosis (Hartley et al., 
1994) . However, global indices of lung density are much less useful for the 
assessment of interstitial lung disease compared with emphysema. There are a 
number of reasons for this: ﬁrstly, areas of decreased attenuation such as the cystic 
spaces of honeycombing and traction bronchial dilatation are oset by the increased 
attenuation of reticulation, the borders of honeycomb cysts and areas of ground 
glass consolidation; secondly, IIP is by deﬁnition a spatially heterogenous disease 
(more so than emphysema) so global measures of lung density cannot reﬂect this. 
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Other problems with using density measurement are the variation with degree of 
inspiration, sensitivity to artefacts (e.g. beam-hardening) and dependence on scanner 
calibration (Parr et al., 2004, Coxson, 2013). 
1.4.4 Analysis of the CT density histogram
Initial attempts to produce a more sophisticated measurement than MLD have 
focussed on analysis of the shape of the CT density histogram, a distribution 
representing the densities of all the pixels/voxels in a CT scan. Various metrics can 
then be used to describe the shape of the histogram, including kurtosis and 
skewness. Kurtosis describes how ‘peaked’ the histogram is compared with the 
normal distribution, which is considered to have a kurtosis of zero. A histogram 
which is more peaked than the normal distribution is said to have a positive kurtosis 
or to be leptokurtic, whilst a histogram which is ﬂatter than the standard normal 
distribution is said to have a negative kurtosis or to be platykurtic. Skewness 
describes deviations in symmetry of a distribution compared with the symmetrical 
normal distribution. If the left tail of a distribution is longer than the right, it is said to 
be skewed to the left or negatively skewed. Positive skewness describes a distribution 
where the right tail is longer than the left. The CT density histogram of normal lung is 
strongly skewed to the left with a sharp peak around -800 HU (negative skewness 
and positive kurtosis). An illustration of the histogram distribution of a region of 
normal lung is shown below (Figure 1-4). This image was produced using the Osirix™ 
open source software (© Pixmeo Sarl).
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Figure 1-4 Region of interest (inside blue dots) of a slice of normal lung with its corresponding 
histogram. Note the sharp, narrow peak. 
Pulmonary ﬁbrosis typically causes an increase in the amount of soft tissue density 
(higher densities) in the lung and therefore causes an increase in mean lung density, 
a reduction in the peak and increased skewness to the left (Hartley et al., 1994). An 
example of the histogram from a patient with pulmonary ﬁbrosis is shown in Figure 
1-5. 
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Figure 1-5 Region of interest (inside blue dots) of a slice of ﬁbrotic lung with its 
corresponding histogram. There is a wider peak, larger right sided ‘tail’ and lower peak (NB: x-
axis is automatically scaled on Osirix™). 
Best et al (Best et al., 2003), in a study of 144 patients enrolled in a therapeutic trial, 
demonstrated moderate correlation between PFTS and kurtosis (r=0.53) but found 
relatively poor correlation between DLCO and all histogram features, despite DLCO 
being widely accepted as one of the most sensitive physiological measure of IIP. This 
study was limited by several factors including: retrospective design; CT scans 
obtained from 30 dierent institutions; CT scanners from 5 dierent manufacturers 
and lack of a standardised image acquisition protocol. Scans were typically acquired 
with a 2 cm interval between slices and manual correction was required to remove 
central airways and blood vessels. 
Zavaletta et al (Zavaletta et al., 2007) used a more complex histogram-based method 
to analyse CT scans from patients with IPF. The method involved adaptive binning of 
the density histogram (using K-means clustering), followed by creation of a canonical 
signature for 5 sub-classes of lung pattern (normal, reticular, ground glass, 
honeycombing and emphysema). Fourteen scans were classiﬁed by 3 expert 
radiologists into volumes of interest (VOIs) containing at least 70% of a lung pattern 
(reticulation, honeycombing, ground glass opaciﬁcation, normal and emphysema) 
and these VOIs were used to train the classiﬁer. The classiﬁer was also trained on four 
whole (volumetric) scans. The algorithm was highly successful in distinguishing 
normal areas of lung from abnormal (sensitivity 93%, speciﬁcity 94%) but was less 
successful at distinguishing all 5 types of pattern with the following sensitivities and 
speciﬁcities: normal (92%, 95%), ground glass (75%, 89%), reticular (22%, 92%), 
honeycombing (74%, 91%), emphysema (94%, 98%). It is noteworthy that the least 
successful classiﬁcation is in cases of ground glass opaciﬁcation and reticular 
pattern. There may be several reasons for this. In terms of ground glass, this is a 
subtle and rather subjective density change which may be seen in normal lung in 
gravity dependent areas and when a scan is performed in relative expiration. In terms 
of reticulation, one of the major challenges is how to distinguish a linear ‘reticulation’ 
from a blood vessel. Both may be of similar width in cross-sectional diameter and of 
similar density. Whilst the authors attempted a semi-automatic segmentation and 
removal of blood vessels greater than one-third of the size of the VOI, they admitted 
that removal of smaller blood vessels is not yet reliably achievable in patients aected 
by ﬁbrotic lung disease. 
1.4.5 Analysis of lung texture - general approaches
A more sophisticated approach to computerised analysis in IPF is to look at textural 
features of the  lung. This approach has been used in materials science (Mecke, 2000) 
and aims to quantify dierent visual patterns of disease. Since this is an important 
element of a radiologist’s reading of a CT, automated textural analysis is a logical 
approach to the quantiﬁcation of disease. Uppaluri et al developed an adaptive 
multiple feature method (AMFM) for the assessment of emphysema and then 
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extended this to the assessment of idiopathic pulmonary ﬁbrosis (Uppaluri et al., 
1999). The AMFM used in the emphysema study had the following stages: 1. Lung 
segmentation 2. Pre-processing of the scan using ‘edgmentation’ – a region-growing 
technique that merges adjacent pixels where the dierence in grey level of the pixels 
is small and then assigns a single grey level to the whole region based on the average 
of the pixels within the region. 3. Regions of interest deﬁned on the original and pre-
processed image. 4. Feature extraction - ﬁve ﬁrst-order features (mean, variance, 
skewness, kurtosis and grey-level entropy) and eleven second order features (ﬁve 
run-length features: short-run emphasis, long-run emphasis, grey-level non-
uniformity, run-length non-uniformity, run percentage and six co-occurrence matrix 
features: angular second moment, entropy, inertia, contrast, correlation, inverse 
dierence moment). 
Whilst Uppaluri et al analysed multiple dierent features prior to selecting those 
which were most discriminating, Uchiyama et al (Uchiyama et al., 2003) pre-selected 
6 features designed to address the speciﬁc task. Of the 6 pre-determined features, 
there were 3 grey-scale distribution measures including the mean CT value of an ROI, 
the standard deviation of CT values in an ROI and the fraction of lung with density 
between -910 HU and -1000 HU in an ROI. The other three features were shape 
measures including measures of nodularity, linearity and multi-loculation. An 
artiﬁcial neural network algorithm was used, with training based on 315 slices 
marked up by 3 radiologists and comprising the following textures: ground-glass 
opacity; reticular and linear opacities; nodular opacities; honeycombing; 
emphysematous change and consolidation. Two other mark-up labels were employed 
but not used for training the algorithm, namely ‘non-speciﬁc/indeterminate’ and 
‘other’ which included any other abnormal feature such as atelectasis, bullae or 
artefact. The algorithm was able to reliably distinguish honeycombing from normal 
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and ground glass opacity, but ground glass opacity showed some overlap with 
normal lung. They also found it dicult to distinguish nodularity from normal lung, 
presumably partly due to the non-spiral nature of the CT scans and the fact that 
blood vessels may appear very similar to nodules in cross-section. Of 53 
indeterminate slices, the algorithm classiﬁed 28 as normal and 25 as abnormal.
Sluimer et al (Sluimer et al., 2006) developed an algorithm for the textural analysis of 
diuse parenchymal lung disease using two dierent sets of texture-analysis 
features, one that they had previously described and a set based on the Uchiyama 
method. They classiﬁed lung into one of six classes: normal, hyperlucent, ﬁbrotic 
(including reticulation, honeycombing and traction bronchial dilatation in association 
with ground glass), ground glass, solid and focal (including solid and ground glass 
nodules, mucus-plugging, scars).
They did not ﬁnd any signiﬁcant dierence in the performance of the system 
depending on which of the  two texture-analysis feature sets was used. One 
interesting feature of their approach was the use of non-square regions of interest, 
designed to encompass more of an area of interest and ensure it contained a more 
homogenous texture. This approach improved the performance of the algorithm with 
up to a 10% increase in the area under the ROC curve. 
In a more recent study, Yoon et al (Yoon et al., 2013) used a texture-based 
automated quantiﬁcation system (AQS) to assess 89 patients with ﬁbrotic interstitial 
lung disease (71 UIP and 18 ﬁbrotic NSIP) each of whom had 2 CT scans performed 
one year apart. The AQS classiﬁed the lung on each CT slice into the following 
categories: normal, emphysema, ground glass opaciﬁcation, reticular opacities, 
honeycombing or consolidation and calculated the percentage of lung aected by 
each category. Interestingly, they used round ROIs with a diameter of 10 pixels 
whereas most studies use square ROIs. They also calculated the total abnormal lung 
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fraction (sum of all abnormal lung categories) and a ﬁbrosis score (sum of 
honeycombing and reticular opacity). The AQS was compared with visual readings by 
2 radiologists who visually estimated the percentage of involved lung on each CT 
slice. The CT scans were not volumetric but rather 0.75 mm slices, which were 
obtained at 10 mm intervals. Interclass correlation coecient (ICC) was used to 
assess the degree of inter-reader agreement and the degree of agreement between 
reader 1 and the AQS, reader 2 and the AQS and the mean of the two radiologist 
scores and the AQS. Scores were also compared with the patient’s FVC and DLCO. 
There was good agreement between both readers and the AQS in terms of fraction of 
emphysema and honeycombing (ICC 0.70 - 0.79 and 0.62 - 0.79 respectively) but the 
readers had less good agreement in terms of reticular opacity (ICC 0.49). Both readers 
had relatively poor agreement with the AQS in terms of ground glass opaciﬁcation (R1 
and AQS = 0.36, R2 and AQS = 0.44) and relatively poor agreement with the AQS in 
terms of reticular opaciﬁcation (R1 and AQS = 0.32, R2 and AQS = 0.40). Reader 1 
had relatively good agreement with AQS in terms of consolidation (ICC = 0.66) but 
reader 2 had less good agreement (ICC = 0.39). Agreement at the one-year follow up 
scan was not so good, with poor agreement between radiologists and the AQS in 
terms of whether there was interval change in the percentage of aected lung.
1.4.6 Analysis of lung texture - Minkowski functionals
Minkowski functionals (MFs) are a group of integral geometry measures that describe 
the geometry and topology of an image and have been used in both materials science 
and cosmology. In 3D, there are 4 dierent MFs which are proportional to volume, 
surface area, mean breadth and the Euler-Poincaré characteristic. A precursor to 
analysis of MFs is to binarise the image so that all pixels are either black or white. 
This can be done at a number of dierent pre-deﬁned density (Hounsﬁeld Unit) 
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thresholds or at an adaptive threshold which is selected depending on the image 
properties. The topological features are based on the connectivity of the pixels in an 
image. Connectivity can be expressed as either 4-connectivity, in which a square 
pixel is said to be connected to an adjacent pixel if it contacts one whole side of that 
pixel or as 8-connectivity, in which a pixel is said to be connected even if it only 
contacts a corner of the pixel (ﬁgure 1-6). 
Figure 1-6 4-connectivity (left) and 8-connectivity (right)
The ﬁrst report of MFs for the analysis of thoracic CT scans was proposed by Boehm 
et al in 2008 (Boehm et al., 2008). They used MFs to analyse a total of 275 volumes of 
interest from 7 patients with emphysema, 7 patients with pulmonary ﬁbrosis and 7 
patients with normal lungs. All these VOIs were cubic volumes with edge length of 40 
pixels. Only a proportion of each scan was sampled. Computerised classiﬁcation of 
pathological subtype (emphysema, ﬁbrosis or normal) was compared with 
classiﬁcation by 2 radiologists. They found that the computer algorithm agreed with 
radiologist classiﬁcation in 98% of normal VOIs and in 86% of ﬁbrotic VOIs. In 2010, 
this work was extended by Thonnes et al (Thönnes et al., 2010) with use of smaller 
VOIs (approximately 5 x 5 x 1 voxels). A total of 10 ﬁbrotic, 10 normal and 8 
emphysematous VOIs were analysed with a mis-classiﬁcation rate of 7%. The 
advantage of the smaller VOIs is to increase the spatial accuracy of classiﬁcation, 
although image noise may be more of a problem. 
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1.5 CONCLUSION AND THESIS STRUCTURE
In summary, there is a need for more accurate methods of assessing the severity of 
IIP and measuring change in disease over time. Methods of quantiﬁcation have 
progressed from visual estimates, to single quantitative metrics to the assessment of 
multiple textural features. Further work needs to be done to assess the use of these 
metrics in a prospective study with strictly controlled scanning parameters and 
detailed clinical correlation. In this thesis we will report on the  development and 
testing of a computer algorithm to analyse lung texture in CFIP, followed by its 
application to scans from a group of prospectively recruited patients. The computer 
output will be compared with radiologists visual estimation, with physiological 
measures of lung function and with a questionnaire-based assessment of patient 
symptoms and wellbeing. Chapter 2 will describe the methodology of the study, 
Chapter 3 will describe the testing of the computer algorithm on a number of pre-
selected, retrospectively-obtained normal and abnormal CT scans, Chapter 4 will 
describe the results of the prospective study in terms of comparing the computer and 
radiologist output, Chapter 5 will describe the comparison of the computer output 
with lung function tests and the symptom and well-being questionnaire, Chapter 6 
will comprise an overall discussion of the results and Chapter 7 will discuss future 
directions. 
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CHAPTER 2: MATERIALS AND METHODS
2.1 INTRODUCTION TO CHAPTER
In this chapter we will discuss the study design including patient recruitment, ethics 
approval, patient selection and sample size. We will then discuss the timeline of study 
visits and the variables measured at each visit, including a detailed description of the CT 
scanning protocol. This is followed by an account of the automatic computerised 
quantiﬁcation algorithm, detailing its design and development. Finally we describe the 
procedure for radiologist visual scoring of CT scans and the planned statistical analysis. 
The computer analysis work was done in collaboration with Dr Abhir Bhalerao at the 
Department of Computer Science at Warwick University, who also kindly supplied 
Figures 2-2 to 2-5. 
2.2 STUDY DESIGN 
2.2.1. Study overview/aims
The work in this thesis forms part of a larger study, the Quantiﬁcation of Interstitial lung 
disease on CT (QUIC) study. The QUIC study is a prospective longitudinal cohort study of 
patients with idiopathic interstitial pneumonia. The primary aim of the QUIC study is to 
see if change in ﬁbrosis on CT, as assessed by an automated computer algorithm, is a 
better predictor of mortality at 5 years than change in pulmonary function tests. 
Therefore, the primary outcome measure was all cause mortality at 5 years. Secondary 
aims were to compare automated computerised estimation of ﬁbrosis with radiologist 
estimation of ﬁbrosis, pulmonary function tests and a patient-reported outcome 
measure. 
Due to delays in starting the study and the fact that recruitment that was slower than 
expected, this thesis will focus on the baseline results from the ﬁrst 24 patients which 
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were recruited and we will not therefore address the primary outcome measure in this 
thesis. Therefore the aim of the current thesis is to describe the development and 
testing of a novel computer algorithm based on Minkowski functionals for the 
quantiﬁcation of CFIP on CT. 
2.2.2 Ethical approval
Full ethical approval was obtained from the West Midlands Research Ethics Committee 
(study reference 11/WM/0387). 
2.2.3 Study population
The study population consisted of patients with a diagnosis of chronic ﬁbrotic 
interstitial pneumonia (CFIP) based on clinical ﬁndings and either a surgical lung biopsy 
showing UIP or NSIP and/or a CT showing a typical UIP pattern as described by Raghu et 
al (Raghu et al., 2011). All patients were discussed at the bi-weekly regional interstitial 
lung disease multi-disciplinary team meeting at University Hospital Coventry and 
Warwickshire NHS Trust, where a consensus diagnosis was documented. The table below 
shows the patient inclusion and exclusion criteria:
Inclusion criteria Exclusion criteria
Diagnosis of CFIP based on clinical ﬁndings 
and either lung biopsy and/or CT scan
Clinical, biopsy or CT ﬁndings suggesting a 
secondary cause of interstitial lung disease
Age greater than or equal to 40 years. Age less than 40 years
Ability to provide informed consent Inability to provide informed consent
Ability to breath-hold or lie ﬂat for the CT 
scan
Inability to breath-hold or lie ﬂat for the CT 
scan
Pregnancy
Table 2-1 Patient inclusion and exclusion criteria
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2.2.4 Patient recruitment
Patients who were thought potentially suitable for the study were approached by their 
usual physician during their routine outpatient appointments. If they expressed an 
interest in participating in the study, they were given a copy of the patient information 
leaﬂet. They were invited to take this away, think about the study and contact the study 
co-ordinator if they decided they would like to participate.
2.2.5 Sample size calculation
We planned to recruit a total of 80 patients with idiopathic interstitial pneumonia (UIP or 
NSIP), averaging 1-2 patients a week. UIP has a mortality of 50-70% at 5 years whilst 
idiopathic NSIP has a mortality of approximately 20% at 5 years. Therefore we expected 
half the patients to be alive at 5 years. Assuming a linear regression model linking 
radiological change to time to death, for 4 predictor variables and a sample of 80 
patients we would have approximately 80% power to detect a medium eect size (R2 = 
0.13), at the 5% signiﬁcance level (Cohen, 1988).
Previous studies have examined between 39 (Xaubet et al., 1998) and 109 patients 
(Flaherty et al., 2003b) with CFIP and have analysed the relationships between ﬁndings 
at HRCT and changes in DLCO and FVC. Flaherty et al (Flaherty et al., 2003b) showed that 
a greater than 10% change in FVC over 6 months was an independent predictor of 
mortality. They did not ﬁnd any predictive value of changes on CT, as assessed by a 
semi-quantitative visual scoring system but suggested that use of a computerised 
scoring system may be more sensitive. Xaubet et al (Xaubet et al., 1998) studied 39 
patients who underwent 2 CT examinations at a mean interval of 7.5 months. With a 
semi-quantitative visual scoring system they showed an approximately 7% change in 
global disease score between scans and found that this change was signiﬁcantly 
correlated with DLCO and FVC. We therefore concluded that 80 was an appropriate 
number of patients to recruit. At the time of writing, 24 patients have been recruited. 
2.3 STUDY VISITS
2.3.1 Schedule of visits
The QUIC study protocol speciﬁed that patients should undergo a total of 5 study visits 
over a 24 month period. A detailed case record form (CRF) was completed at baseline 
(appendix A) and a shortened CRF was completed at each subsequent visit. The St 
George’s Respiratory Questionnaire  (Appendix B) and full pulmonary function tests 
were completed at each visit. Screening blood tests were performed at the ﬁrst visit 
including: full blood count; urea and electrolytes; liver function tests; creatine kinase; 
rheumatoid factor; anti-CCP titre and nuclear antibodies. The latter four tests were to 
look for possible connective tissue disease. 
CT scans were performed at 0, 3, 12 and 24 months. All other tests were performed at 0, 
3, 6, 12 and 24 months. As previously mentioned, this thesis will be limited to analysis 
of the baseline investigations. 
2.3.2  Clinical assessment/case record form
Patients were each assessed by one of the study respiratory physicians (DP or FW), both 
of whom have a subspecialty interest in interstitial lung disease. A diagnosis of CFIP was 
only made only once secondary causes of interstitial pneumonia had been excluded. 
Secondary causes included exposure to inorganic dusts (pneumoconioses), organic 
dusts (hypersensitivity pneumonitis) or therapeutic agents known to cause interstitial 
lung disease. Patients were questioned about symptoms associated with collagen 
vascular disease and examined for signs of these conditions. Patients were designated 
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to have a CFIP if they did not have a secondary cause and did not fulﬁll the criteria for a 
deﬁned rheumatological condition. 
The CRF was designed to capture information about all current and previous medical 
conditions, current medication and exposures to possible toxic agents (including a 
detailed occupational history). The CRF was also used to record lung function and blood 
test results. 
2.3.3  St George’s Hospital Respiratory Questionnaire
The St George’s Hospital Respiratory Questionnaire (STGRQ) was used to assess the 
severity of patients’ symptoms and their impact on their daily activities. The STGRQ is a 
50 item disease-speciﬁc questionnaire which was originally designed to be used in 
patients with chronic obstructive airways disease (COPD) and asthma (Jones et al., 1992). 
The questionnaire has two parts. The ﬁrst part asks the patient about their symptoms in 
the preceding 3 months and produces the ‘symptoms’ score. The second part is 
concerned with how patients are functioning currently, how their disease aects their 
physical functioning (the ‘activities’ domain), how it aects their psychological state and  
how it aects their social functioning (the ‘impacts’ domain). The full questionnaire is 
reproduced in Appendix B. The highest maximum total STGRQ score is 100 and the 
highest score for each of the domains is also 100. A higher score indicates a greater 
degree of limitation. Each response is individually weighted and the domain/total scores 
are calculated using a free custom-designed excel spreadsheet supplied by the St 
George’s group. The questionnaire was developed by Professor Paul Jones at St George’s 
Hospital and although originally validated for the assessment of patients with asthma 
and COPD (Jones et al., 1991, Jones et al., 1992), it has also been used in a number of 
studies of IPF. For example, in their 2005 systematic review of the use of health related 
quality of life (HRQL) questionnaires in IPF, Swigris et al (Swigris et al., 2005) found 7 
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studies which met their inclusion criteria and which enrolled between 10 and 330 
patients into various studies (median 34 patients). All of these studies administered 
their questionnaires at a single time-point. Three of the studies used the STGRQ, three 
used a generic (not respiratory speciﬁc) HRQL questionnaire called the ‘short form 
36’ (SF-36) (Ware Jr and Sherbourne, 1992), and two used a generic quality of life form  
developed by the World Health Organisation (WHOQOL-100) (group, 1995). The SF-36 
and WHOQOL-100 both look at multiple aspects of wellbeing and health, whereas the 
STGRQ is speciﬁc to patients with respiratory disease. Five of the studies were cross-
sectional in design and two were therapeutic trials. Only one of the studies was 
speciﬁcally designed to try to validate the use of the HRQL questionnaire in IPF. This 
cross-sectional study by Martinez et al (Martinez et al., 2000) compared 34 patients with 
IPF with 34 age and sex-matched controls. They administered the SF-36 questionnaire 
and another respiratory questionnaire, the Baseline Dyspnea Index (BDI) (Mahler et al., 
1984), to IPF patients and controls; IPF patients also underwent pulmonary function 
tests and resting arterial blood gas measurements. They found that the IPF patients 
scored signiﬁcantly lower than normal subjects on 7 out of 8 components of the SF-36. 
They also found that there was signiﬁcant correlation between ﬁve of the SF-36 score 
components and the BDI and that there was signiﬁcant correlation between two 
components of the SF-36 score (physical functioning and general health perceptions) 
and spirometry (FEV1 and FVC). 
More recently, Swigris et al (Swigris et al., 2010) looked to further validate the SF-36 and 
the STGRQ in a large group of patients with IPF and try to estimate the minimum 
important dierences in scores for the two questionnaires. The data was collected as 
part of the BUILD-1 study of the use of Bosanten in IPF. The questionnaires were 
administered to 158 patients with IPF who were randomised to receive either Bosanten 
or placebo. They found that changes in both the SF-36 and STGRQ reﬂected changes in 
47
patients disease progression (as assessed by the BDI, FVC and DLCO). They found that the 
minimum important dierence in scores was 2-4 for SF-36 and 5-8 for STGRQ. 
2.3.4 Pulmonary Function Tests
All patients underwent full lung function tests at baseline including spirometry (FEV1, 
FVC), lung volumes (TLC, RV, ERV and FRC) and transfer factor (TLCO, KCO, VA). TLC was 
measured using the helium dilution technique and DLCO was measured using the single 
breath technique.
2.3.5 CT scans
The study protocol speciﬁed that scans should be performed within 2 weeks of 
pulmonary function tests. All patients were scanned on a state of the art 64-slice CT 
scanner (Discovery HD - GE Healthcare, Milwaukee, WIS). The following table details the 
CT scan parameters and the choice of parameters is described in more detail below:
Parameter Setting
Number of detectors 64
Pitch 0.98
kV 120
mA 100
Slice thickness (mm) 0.625
Reconstruction algorithms Bone, Lung and Standard
Table 2-2 CT scan parameters
2.3.5.1 Spiral vs non-spiral acquisition
In the early days of CT, high-resolution CT (HRCT) of the lungs was performed using a 
non-spiral technique, since acquiring a whole lung volume using thin slices on the 
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earlier generation of CT scanners would take much longer than a reasonably achievable 
breath-hold. Therefore, the percentage of lung scanned had to be sacriﬁced for the 
increased resolution achieved by using thin slices. With the advent of modern multi-
detector scanners it has become possible to obtain whole lung coverage using thin slice 
spiral acquisitions. There are many advantages of this volumetric spiral scanning, 
including the possibility to acquire a dataset which represents the whole of the lungs 
and the ability to reconstruct images in multiple orthogonal planes. For situations where 
serial scans need to be compared volumetric scanning techniques make slice matching 
much easier. For quantitative analysis, spiral acquisition is necessary for 3D-analysis 
techniques to be performed. The potential downside of spiral acquisition is that it 
typically results in a higher patient radiation dose than non-spiral CT and therefore 
non-spiral CT continues to be used in certain circumstances such as in paediatric 
patients. In the older patients who are typically aected by IPF, radiation dose is not 
usually such an important consideration, since older patients are less sensitive to the 
eects of radiation and have less time to develop the potential side eects (Kleinerman, 
2006). 
Another important feature of the study protocol is that patients were scanned from the 
lung bases to the lung apices (caudo-cranially). This is the opposite direction to how 
most CT is obtained. The reason for starting the scan at the lung bases is that during 
normal breathing there is much greater excursion of the lower part of the chest 
compared with the apices. Thus if a patient is unable to hold their breath for the 
duration of the scan, any breathing movement is more likely to aect the apices, which 
are less mobile, thus leading to less breathing artefact.  
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2.3.5.2 Slice thickness
Choice of slice thickness on CT is a compromise between image noise, spatial resolution 
and partial volume eect. Thinner slices have greater image noise (due to less data) but 
have better spatial resolution and decreased partial volume eect. In order to facilitate 
accurate 3D reformatting and analysis of texture, we decided that the CT scan should be 
acquired with the thinnest possible slices achievable on our scanner, which for the GE 
Discovery HD is 0.625 mm. This results in near-isotropic voxels. 
2.3.5.3 Dose parameters - mA and kV
In choosing appropriate levels of mA and kV, consideration must be given to patient 
dose, image noise and image contrast. An increase in mA leads to a linear increase in 
dose, whereas the relationship between kV and dose is non-linear with, for example, a 
20% increase in kV leading to an approximately 30% increase in dose. 
Since the lung shows high inherent contrast between aerated lung and adjacent 
structures, a low dose scan protocol was chosen with a ﬁxed mA of 100 and a ﬁxed kV 
of 120. Previous studies have shown that such low dose protocols do not lead to an 
important decrease in the ability of automated algorithms to detect lung nodules 
(Diederich et al., 1999) and that emphysema quantiﬁcation is not signiﬁcantly hampered 
by thresholds as low as 50 mAs (Zaporozhan et al., 2006). Sverzellati et al performed an 
analysis of histogram features in patients with idiopathic interstitial pneumonia and did 
not ﬁnd any signiﬁcant dierence between scans performed at 50 mAs and scans 
performed at 100 mAs (Sverzellati et al., 2005). 
Speciﬁc dose reduction post processing techniques such as adaptive statistical  iterative 
reconstruction were not used because the eect on automated quantiﬁcation is not yet 
known. 
2.3.5.4 Pitch
The pitch of a multi-detector CT scanner can be deﬁned as the distance moved by the 
table during one rotation, divided by the detector collimation (total length of detectors) 
(Schilham et al., 2010) and can be thought of in terms of how tightly a spring is coiled, 
imagining the beam of the x-ray tube tracing a spiral around the patient. A pitch of 1 
means a spring where there are no gaps between the coils of the spring but no 
overlapping of coils. Therefore during a single 360 rotation of the x-ray tube, each 
element within the body is sampled twice. A pitch of less than 1 implies overlapping and 
a pitch of more than 1 implies ‘gaps’ between the springs and reduced sampling. For our 
study, a pitch as near as possible to 1 (0.98) was chosen as a compromise between the 
reduced amount of data acquired with a pitch of more than 1 and the oversampling and 
increased dose of a pitch less than 1. 
2.3.5.5 Reconstruction algorithm
CT raw data can be reconstructed in multiple dierent ways using dierent 
mathematical algorithms. A number of studies have examined the eect of using 
dierent reconstruction algorithms on automated quantiﬁcation of emphysema. They 
concluded that most accurate results were obtained with use of a ‘soft tissue’ algorithm. 
Studies of the eect of algorithm choice on automated quantiﬁcation of IPF are less 
numerous and a number of dierent algorithms have been used in quantitative studies 
including bone (Maldonado et al., 2014, Sverzellati et al., 2005), lung (Yoon et al., 2013) 
and ‘non-edge enhanced’ (Bartholmai et al., 2013) . At the time of writing, we are not 
aware of any texture-based quantiﬁcation study which compares more than one 
algorithm. 
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2.3.5.6 Window level and width
The CT attenuation of a voxel of tissue is deﬁned by its CT number which is deﬁned as 
the dierence in attenuation of the contents of the voxel relative to water. The CT 
number is expressed in terms of the Hounsﬁeld Unit (HU) where water is assigned a 
value of zero. The window level and width specify the CT numbers which deﬁne the 
midpoint and the range respectively of the gray-level scale used to display a CT image 
(Barnes, 1992). Radiologists viewed all images on standard lung windows (window level 
= - 500 HU, window width =1400 HU). 
2.3.5.7 Level of inspiration/breathing instructions
The QUIC protocol speciﬁes that the scans are performed at full inspiration. The most 
important factor in ensuring that a CT scan of the chest is suitable for quantitative 
analysis is making sure that the patient achieves the appropriate level of inspiration and 
expiration and that the patient holds their breath during the scan (Newell Jr et al., 2013). 
In order to ensure this, speciﬁc breathing instructions were created for the QUIC study 
and pre-programmed onto the scanner. The instructions are given in the table below:
Breathing instructions “Breath in....breath out....breath in.... 
breath out....breath all the way in... and 
stop breathing”
Table 2-3 CT scan breathing instructions
2.4 DEVELOPMENT OF THE AUTOMATED COMPUTERISED ANALYSIS SOFTWARE
2.4.1 Steps required for automated analysis
The process of developing the algorithm was an iterative process building on a previous 
algorithm developed by the Department of Computer Science at Warwick University 
(Charemza et al., 2008). The process can be broken down into a number of steps as 
follows:
 Step 1:  Separation of the lung voxels from the chest wall and the air outside 
 the thorax
 Step 2: Segmentation of the major airways and their removal from the lung 
 volume
 Step 3:  Training the algorithm using marked up data, analysis of the dierent 
 lung textures and development of classiﬁers according to the dierent 
 Minkowski functionals
 Step 4:  Texture analysis of the new lung volume using Minkowski functions.
 Step 5:  Classiﬁcation of the lung voxels according to similarity to the 
 classiﬁer.
In the ﬁrst step, the lung voxels must be separated from surrounding structures. There 
have been many dierent methods described for automatically segmenting the lungs 
from the chest wall which are described in a recent review article by van Rikxoort et al 
(van Rikxoort and van Ginneken, 2013). These methods vary in their sophistication, 
computational eciency and degree of user input required. 
In people with normal lungs the task can be relatively easily accomplished since the lung 
is typically much lower attenuation than the structures of the chest wall. The density of 
normal lung is typically below -500 HU whereas normal chest wall structures are greater 
than -50 HU and there is therefore a large dierence between the two. A process of 
simple thresholding can therefore be used to isolate the lungs using a threshold of, for 
example -100 HU. On the other hand, diseased lung often has increased density and 
may therefore be very similar in attenuation to the adjacent chest wall. This makes 
separation of abnormal lung and the chest wall dicult. Another challenge is that 
diseased lung (e.g. emphysema, honeycomb cysts) may have abnormally low density, 
creating ‘holes’ in the image which may be confused with airways. We chose an approach 
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which uses a combination of thresholding and a ‘shrink-wrapping’ technique. This 
technique has a number of steps, as follows:
1) Segmentation: a basic initial segmentation is performed using an adaptive 
thresholding technique as described by Hu et al (Hu et al., 2001). As shown below 
(Figure 2-1) , this may have some ‘holes’ i.e. fail to include some lung tissue, both at the 
periphery of the lungs and more centrally within the lung parenchyma.
Figure 2-1 Initial segmentation of the lungs using thresholding
2) ‘Shrink-wrapping’: this technique involves generating multiple points on the surface 
of the lung volume and then casting linear rays through these points in order to identify 
points exterior and interior to the surface. A bounding, convex mesh is then initialised 
outside the surface points. Figure 2-2 provides a schematic representation of this using 
a cube and sphere as the object to be segmented. Next, the positions of the mesh are 
updated using a self organising map (SOM).
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Figure 2-2 Convex mesh placed outside the desired volume
This is a type of artiﬁcial neural network where points (called ‘nodes’ or ‘neurons’) are 
assigned to an approximation of the desired structure and then moved in position 
according to their similarities with neighbouring nodes. Multiple iterations of this 
process gradually decrease the size of the polygons forming the mesh and allow it to 
move closer to the desired shape. This procedure was originally described by Kohonen 
et al and therefore SOMs are sometimes known as Kohonen maps (Kohonen, 1982). 
Figure 2-3 shows several iterations of the software as it approximates the lung surface 
and Figure 2-4 shows a 3D surface-rendered representation of the ﬁnal segmented lung 
volume. 
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Figure 2-3 Several iterations of the self-organising map (SOM) showing gradually decreasing 
surface polygon size as the external mesh approximates to the true lung volume
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Figure 2-4 Surface rendered representation of the ﬁnal 3D lung volume after it has been ‘shrink-
wrapped’
3) Removal of airways: the major airways must now be removed from the lung volume. 
The method chosen is based on the approach by Doel et al (Doel et al., 2012). Firstly, a 
seed point is ﬁrst manually placed in the trachea. Next, a region-growing algorithm is 
used whereby neighbouring voxels are grouped together if their density is below a 
threshold of -900 HU. An ‘explosion-control’ mechanism is used to prevent low 
attenuation lesions adjacent to airways being included within the airway volume. This 
mechanism relies on the fact that airways will generally decrease in size over successive 
generations and stipulates that, as the region growing algorithm progresses, the 
number of voxels joining the volume should gradually decrease (apart from small 
temporary increases at airway bifurcations). If there is a sudden increase in the number 
of voxels joining the airway tree, this implies ‘leakage’ into the surrounding lung and 
the process is terminated. Once the airway volume has been ‘grown’, it is subtracted 
from the lung volume. Figure 2-5 (below) shows an example of the extracted airways.
Figure 2-5 Extracted major airways
4) Training: the next stage in the process is to train the software using expert radiologist 
mark-up. In order to provide the algorithm with ground truth data, a Radiologist (EH - 
‘Radiologist 1’), marked up a scan of a patient with IPF. The scan was chosen to be 
representative of all the typical features of IIP and was of a patient with moderate 
severity disease. The algorithm was marked up using a software called ITK-snap (http://
www.itksnap.org), an open-source software which allows the viewing and drawing of 
irregular ROIs on a CT scan saved in DICOM format. These ROIs can be colour-coded to 
indicate dierent types of abnormality and saved in several dierent formats 
(Yushkevich et al., 2006). For the purpose of this study, the .NRRD format was chosen. 
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The labels used and colour codes were as follows:
Texture Colour code Degree of Conﬁdence
Honeycombing Red Deﬁnitely abnormal
Reticulation Green Deﬁnitely abnormal
Emphysema Orange Deﬁnitely abnormal
Ground glass change Yellow Deﬁnitely abnormal
Indeterminate* Cyan Subtly abnormal
Normal Purple Deﬁnitely normal
Table 2-4 Labels for radiologist mark-up of scan 13
Category 5 (indeterminate) was selected when the region of lung did not ﬁt into any of 
the other categories. Generally, this was when the region was only subtly abnormal but 
not abnormal enough to be coded as 1-4. Particular care was taken to only mark as 
normal areas which were deﬁnitely normal, since reliable categorisation of lung into 
normal or abnormal was felt to be one of the most important characteristics of any 
algorithm. 
Initially, the whole right lung of a single scan was marked up. This involved marking up 
409 slices using an average of 7 ROIs per slice producing a total of approximately 2800 
irregular ROIs. This task took approximately 40 hours in total. 
The whole of the lung volume was then divided up by the computer algorithm into non-
overlapping ROIs of 5 x 5 x 5 pixels each. This resulted in 13,855 ROIs which had been 
assigned by the radiologist to the honeycomb class, 14767 reticulation ROIs, 4875 
indeterminate ROIs and 5422 normal ROIs (total 38,919 ROIs - table 2-5). Since there 
were an uneven number of voxels in each class, and in order not to bias the training of 
the algorithm, a total of 3000 voxels of each class were used to train the algorithm. 
Class Number of ROIs
Honeycombing 13855
Reticulation 14767
Indeterminate 4875
Normal 5422
Table 2-5 Number of ROIs marked-up for each class
5) Calculation of Minkowski Functionals: the next stage in training the algorithm was to 
calculate the Minkowski functionals (MFs) for each of the voxels in order to try and 
separate out the dierent classes. The calculation of the MFs can only be performed on 
binary data so the pixel density had ﬁrst to be converted to black or white (rather than 
the 256 shades of grey which are shown in a typical CT image). This can be done at a 
single threshold or at multiple thresholds. We chose to perform the calculations at 100 
thresholds of 10 HU from -1000 to 0. The four MFs were calculated for each of the 100 
thresholds giving 400 samples per ROI. The formula which is used to derive the MFs for 
convex sets is expressed in terms of the volume of a given set when dilated by a ball, Br 
of radius r. In 3D the formula is :
V (K  Br) = V (K) + S (K)r + 2πB (K)r2 + 4/3휒 (K)r3         (Arns et al., 2002)
Where K is a convex set and  is the dilation operation; V= volume; S = surface area, B = mean breadth 
and 휒 = the Euler-Poincare Characteristic (EPC)
Building a classiﬁer: a neural network (NN) using a multi-layer perceptron (MLP) was 
used to build a classiﬁer. This approach is similar to that adopted by Huber et al and is 
suited to dealing with the high-dimensionality of our multiply thresholded features. 
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Having designed a computer algorithm according to the steps listed above, we then 
tested it in a number of dierent situations, as detailed below.
2.4.2 Testing the computer algorithm - control scans
The computer algorithm was ﬁrst tested on normal CT scans, designed to act as 
controls. For this purpose, 7 consecutive high resolution CT scans of the thorax which 
had been reported as normal were selected from the routine CT work-list. These were 
validated by EH as being normal, then fully-anonymised (no patient identiﬁable data) 
and the computer algorithm was run on these scans. Results of this experiment are 
presented in Chapter 3). 
2.4.3 Testing the computer algorithm against a CT scan marked up by a 
radiologist
Next the algorithm was tested on the initial scan (patient 13) which the radiologist had 
marked up for training the algorithm. Although the radiologist had marked up only the 
right lung, the algorithm was applied to both the left and right lungs. Comparison of the 
radiologist mark-up with the computer output for the left lung is discussed in Chapter 3.
2.4.4 Testing the computer algorithm against selected slices marked up 
by a radiologist
The algorithm was tested on multiple scans from prospectively recruited patients. One 
subject (patient 19) was subsequently omitted due to their scan having normalised. 
The output of the computer algorithm was compared with 5 slices per patient which had 
been visually scored by a radiologist. For these scans, all 23 were marked up by at least 
one radiologist and 8 scans were marked up by 2 radiologists. Before being presented to 
the radiologists, all scans were fully anonymised using the GE advantage workstationTM . 
This viewing and post processing workstation has a feature called ‘Anonymous Maker’ 
which enables the removal of all patient identiﬁer and demographic data but allows 
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metadata concerning the scan parameters (e.g. slice thickness, ﬁeld of view, voxel 
dimensions) to be retained. Scans were provided to radiologists for scoring in a random 
order. 
A total of ﬁve slices were selected for the radiologists to score, chosen at 5 pre-
determined anatomical levels as follows: the top of the arch of the aorta, the carina, the 
right superior pulmonary vein, 1 cm above the dome of the diaphragm and 2 cm below 
the dome of the diaphragm. These 5 slices were presented to the radiologists in a 
separate folder for each patient. 
A scoring sheet (Appendix C) was developed based on the work of Edey et al (Edey et al., 
2011) and Goh et al (Goh et al., 2008). Radiologists were provided with speciﬁc scoring 
instructions for this purpose (Appendix D) and were blinded to the results of the 
computerised estimation of ﬁbrosis. To summarise, the scoring process was as follows:
1. For each slice, radiologists were asked to give a visual estimate of the percent of lung 
involved with honeycombing, reticulation, ground glass opaciﬁcation and 
consolidation. Estimates were to be given to the nearest 5%. 
2. Radiologists were asked to report whether they thought there was emphysema on 
each slice, giving a simple yes or no answer. 
The results of the radiologists’ scoring are presented in Chapter 5. 
2.5 STATISTICAL ANALYSIS
Correlation between computer calculated lung volume and TLC was assessed by linear 
regression and was examined for systematic error using Bland-Altman plots (Bland and 
Altman, 1986) . 
Linear regression was used to examine the correlation between the two radiologists, 
between radiologist and computer, and between computer scores, pulmonary function 
tests and respiratory questionnaire scores. Spearman’s rank-order correlation was 
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performed to compare the ranking of scan severity by the computer and radiologist. 
Intraclass correlations were used to compare radiologists’ visual scores. All analysis was 
performed using SPSS statistics software version 22.0.0.0 (SPSS, Chicago, IL). The results 
of these analyses will be presented in Chapter 5. 
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CHAPTER 3: RESULTS PART 1: INITIAL TESTING OF THE COMPUTER 
ALGORITHM
3.1 OVERVIEW OF THE RESULTS CHAPTERS
This is the ﬁrst of three results chapters in which we will discuss the initial testing of the 
computer algorithm including testing on 7 normal (control) scans and a single 
pulmonary ﬁbrosis scan, comparing the output of the computer algorithm on the 
ﬁbrosis scan with radiologist manual segmentation. 
3.2 INTRODUCTION TO CHAPTER 3
In this chapter (Chapter 3) we will discuss the outputs of the computer algorithm on 7 
scans from patients with no lung disease and on a single patient with pulmonary 
ﬁbrosis. We will use the normal scans to look speciﬁcally at dierent sources of error 
and variation in the behaviour of the computer algorithm including artefact at tissue 
boundaries, movement artefact and gravitational eects. We will also assess the 
important inﬂuence of CT reconstruction algorithm and degree of inspiration/expiration 
on the computer output. We will then look at the computerised classiﬁcation of lung 
texture on a scan from a patient with pulmonary ﬁbrosis, including the Minkowski 
functional characteristics of dierent lung textures, and compare the computer 
classiﬁcation with radiologist manual segmentation. 
3.3 COMPUTER ANALYSIS OF NORMAL SCANS
Details of the selection of the normal scans is given in Chapter 2 (Materials and 
Methods). We will ﬁrst describe examine how the computer algorithm classiﬁed the 7 
normal scans when performed in full inspiration and reconstructed using the bone 
algorithm (the algorithm that the software was trained on), focussing speciﬁcally on 
accuracy of segmentation and classiﬁcation. Several representative slices of the normal 
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scans will be presented, along with a table showing the variation in lung texture 
classiﬁcation between the scans. We will then look at the eect of CT reconstruction 
algorithm on 5 of the 7 scans which had been reconstructed using three dierent 
algorithms (bone, standard and lung). Finally we will look at the eect of lung volume on 
two of the normal scans which were performed in both inspiration and expiration. 
3.3.1 Computer segmentation and classiﬁcation of 7 normal inspiratory 
scans
Normal scan 1:
The overall segmentation for this scan was good but it can be seen that there is mis-
classiﬁcation of some of the most peripheral voxels as honeycombing. This is seen as a 
universal phenomenon on all scans and is believed to be due to inclusion of some soft 
tissue of the chest wall in these voxels (partial volume eect). We can also see that there 
is some erroneous inclusion of the hilar vessels in the segmented lung component. 
These two sources of error can be seen in the ﬁgure below: 
Figure 3-1 Computer output on axial slice of normal scan 1 at the level of the carina
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This scan also suered from some breathing artefact at the lung bases and some cardiac 
pulsation artefact. The breathing artefact led to some ‘ghosting’ of the diaphragm onto 
the lung parenchyma (Figure 3-2). 
Figure 3-2 Computer output on axial slice of normal scan 1 at the level of the diaphragm
It is evident that this led to both segmentation issues and texture classiﬁcation issues 
with some of the ghosted diaphragm included in the segmented lung and some omitted. 
The lung that was included was classiﬁed as either honeycombing or reticulation. 
Cardiac pulsation artefact was also present on this scan and led to some normal lung 
being classiﬁed as ‘indeterminate’ (Figure 3-3). 
*
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Figure 3-3 Computer output on axial slice of normal scan 1 at the level of the heart. Large area of 
blue colouration in the left lung is consistent with cardiac pulsation artefact (asterisk)
Normal scan 2:
This scan showed good segmentation but experienced problems with texture 
classiﬁcation at the posterior basal parts of the lung (Figure 3-4)
Figure 3-4 Computer output on axial slice of normal scan 2 at the level of the heart. Note the 
large volume of indeterminate lung (blue) and the erroneous reticulation classiﬁcation at the lung 
bases (green). 
This was felt to be due mainly due to the degree of noise aecting the scan with a lot of 
streak artefact posteriorly. This linear streaking was misinterpreted by the computer 
algorithm as being reticulation and illustrates the fact that it may not be possible to 
distinguish between dierent types of linear abnormality. This scan was also rather 
expiratory and this led to a large amount of the lung being classiﬁed as indeterminate. 
Further analysis of inspiratory/expiratory acquisitions is discussed in Section 3.3.3. 
Normal scan 3:
This scan again demonstrates the edge artefact which gives a spurious band of 
honeycomb classiﬁcation around the lung edges. It also shows areas of ‘indeterminate’ 
classiﬁcation posteriorly which is thought to be due to a gravitational gradient in lung 
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density (ﬁgure 3-5). This phenomenon has previously been described in studies of CT 
lung density in normal patients who were imaged supine and prone at dierent degrees 
of inspiration (Verschakelen et al., 1993).
Figure 3-5 Computer output on axial slice of normal scan 3 at the level of the heart. Note the 
large volume of ‘indeterminate’ classiﬁcation which is thought to be due to a gravitational change 
in lung density
Normal scan 4:
This shows similar ﬁndings to scan 3 but with less of the indeterminate classiﬁcation 
(see ﬁgure below):
Figure 3-6 Computer output on axial slice of normal scan 4 at the level of the heart showing a 
small amount of indeterminate classiﬁcation posteriorly (arrows)
68
Normal scan 5
The output from scan 5 was similar to that from scan 3, containing a moderate amount 
of indeterminate classiﬁcation and some erroneous reticulation due to posterior streak 
artefact (Figure 3-7).
Figure 3-7 Computer output on axial slice of normal scan 5 at the level of the heart
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Normal Texture Volumes:
The table below (Table 3-1) summarises the percentage of lung volume classiﬁed as 
each texture in the 7 normal inspiratory scans. This table also shows the percentage of 
voxels classiﬁed as honeycombing which were at the lung edge (surface voxels). 
Total
Honeycomb
(a)
Honeycomb 
surface 
voxels
Reticulation
(b)
Total 
ﬁbrosis 
(a+b)
Indeterminate
(c)
Normal
(d)
Non 
ﬁbrosed
(c+d)
Normal 1 11.4 8.4 2.8 14.1 6.7 79.2 85.9
Normal 2 13.1 9.0 15.3 28.4 54.9 16.8 71.6
Normal 3 11.1 8.0 5.5 16.6 45.7 37.7 83.4
Normal 4 9.2 6.8 4.3 13.5 14.0 72.5 86.5
Normal 5 9.0 7.2 4.4 13.4 33.8 52.7 86.6
Normal 6 9.6 7.1 2.3 11.9 5.9 82.2 88.1
Normal 7 11.1 7.6 1.4 12.4 2.9 84.7 87.6
Mean 
(SD)
10.6 (1.5) 7.7 (0.8) 5.1 (4.7) 15.8 (5.8) 23.4 (21.2) 60.8 (26.0) 84.2 (5.8)
Table 3-1 Classiﬁcation of lung texture in 7 normal scans (bone algorithm). All ﬁgures are given 
as percentages
From this table it can be seen that there is a percentage of lung which is incorrectly 
classiﬁed as honeycombing on each of the normal scans (false positive honeycombing). 
This can be explained mainly by segmentation errors including at the interface between 
lung and chest wall, between lung and mediastinum and at the hila (incorrect inclusion 
of large airways and vessels in the lung volume). We can see that the percentage of lung 
classiﬁed as honeycombing which was at the edge of the segmentation has a mean 
volume of 7.7% (SD 0.78). The consistent nature of this error with a small standard 
deviation suggests that, if it is not correctable on future algorithms, it could eectively 
be subtracted from the ﬁnal estimate of honeycombing.
Incorrect classiﬁcation of normal lung as reticulation was generally less of a problem but 
also tended to occur at interfaces between lung and soft tissue. An exception was 
Normal scan 2 where excessive posterior streak artefact led to increased false positive 
reticulation. As previously described, indeterminate lung was thought to be a reﬂection 
of gravity dependent increased density or increased density due to an expiratory scan. 
This is further explored in Section 3.3.3. 
3.3.2 Eect of CT reconstruction algorithm on normal scans
The table below (Table 3-2) illustrates the eect of the CT reconstruction algorithm 
on texture classiﬁcation for ﬁve of the normal scans for which three separate 
reconstruction algorithms were available, all with the same slice thickness (lung, 
standard and bone algorithms). 
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Lung Standard Bone 
Normal 1 Honeycomb (%) 39.1 7.3 11.4
Reticulation (%) 1.3 6.3 2.7
Indeterminate (%) 1.8 5.6 6.7
Normal (%) 57.8 80.8 79.2
Normal 2 Honeycomb (%) 51.3 6.9 13.1
Reticulation (%) 7.2 17.0 15.3
Indeterminate (%) 19.7 49.6 54.9
Normal (%) 21.8 26.5 16.8
Normal 3 Honeycomb (%) 34.2 5.6 11.1
Reticulation (%) 1.7 10.7 5.5
Indeterminate (%) 18.0 31.2 45.7
Normal (%) 46.2 52.6 37.7
Normal 4 Honeycomb (%) 26.1 5.9 9.1
Reticulation (%) 2.5 7.1 4.3
Indeterminate (%) 6.2 11.8 14.0
Normal (%) 65.2 75.2 72.5
Normal 5 Honeycomb (%) 35.7 5.6 9.0
Reticulation (%) 1.6 8.7 4.4
Indeterminate (%) 13.2 24.3 33.8
Normal (%) 49.5 61.4 52.7
Table 3-2 Eect of dierent reconstruction algorithms on classiﬁcation of lung texture on normal 
scans
This table shows that the choice of CT algorithm has a signiﬁcant eect on the 
classiﬁcation of the lung. 
Several conclusions can be drawn from the data, as follows:
1) The lung algorithm leads to signiﬁcantly more lung being wrongly assigned to the 
honeycombing class. The mean percentage honeycombing for the 7 normal scans with 
lung algorithm is 37.3% (SD = 9.2%) compared with 6.3% (SD = 0.8%)  for the standard 
algorithm  and 10.6% (SD = 1.7%) for the bone algorithm . The reason for this appears to 
be two-fold. Firstly, a large proportion of smaller vessels are mis-classiﬁed as 
honeycombing and secondly, there is an exaggeration of the tendency to classify voxels 
at the costal and mediastinal borders as honeycombing. This eect is demonstrated in 
ﬁgure 3-8 below.
Figure 3-8 Selected axial slice from normal scan 1 showing vessels mis-classiﬁed as 
honeycombing (red) using the lung algorithm (left hand image) compared with the bone algorithm 
(right hand image)
2) The amount of lung which is mis-classiﬁed as reticulation is proportionally greater 
when using the standard algorithm and the amount of mis-classiﬁcation as 
reticulation is least marked when using lung algorithm.
3) The bone algorithm gives results which are somewhere in between lung and standard 
algorithms.  
4) The amount of lung which is classiﬁed as indeterminate is largest with the bone 
algorithm with progressively lower proportions of indeterminate classiﬁcation on the 
standard and lung algorithms.
5) The standard algorithm consistently gives the greatest portion of normal 
classiﬁcation with bone and standard in second or third place depending on the scan. 
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3.3.3  Eect of inspiration/expiration on normal scans
Two of the normal scans (normal 6 and 7) had both inspiratory and expiratory images 
available. These are discussed below:
Normal scan 6 - inspiration
This scan showed overall good segmentation of the inspiratory images (see ﬁgure 3-9 
and 3-10) with just minor edge artefact and cardiac pulsation artefact.
Figure 3-9 Normal scan 6 performed in inspiration (bone algorithm) showing minor edge artefact
*
Figure 3-10 Normal scan 6 performed in full inspiration shows minor edge artefact and cardiac 
pulsation artefact (*)
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Normal scan 6 - expiration
Expiration had a signiﬁcant eect on the classiﬁcation of the lung producing an 
increased percentage of lung incorrectly classiﬁed as indeterminate or reticulation. 
Figure 3-11 below shows a similar slice to ﬁgure 3-10 (note position of oblique ﬁssures) 
and demonstrates that although the slice does not look very dierent visually, there is a 
dramatic dierence in texture classiﬁcation. 
Figure 3-11 Normal scan 6 performed in expiration showing a large amount of indeterminate 
classiﬁcation (blue)
Normal scan 7 - inspiration
The inspiratory images of normal scan 7 classiﬁed well, apart from some minor mis-
classiﬁcation of posterior lung, thought to be due to posterior linear streak artefact 
(Figure 3-12). The expiratory images showed a large amount of indeterminate lung as 
well as a small amount of spurious reticulation. Figure 3-12 and Figure 3-13 show a 
similar level slice on the same subject performed in inspiration and expiration. 
Figure 3-12 Normal scan 7 performed in full inspiration shows minor streak artefact posteriorly 
which has been mis-classiﬁed as honeycombing (arrows)  
Figure 3-13 Normal scan 7 performed at full expiration shows a large amount of indeterminate 
lung (blue) as well as a small amount of erroneous reticulation (green)
Interestingly, the inspiratory/expiratory nature of the scan aected mis-classiﬁcation of 
dierent lung textures dierently and dierent algorithms were more sensitive to the 
degree of inspiration/expiration. 
This can be seen in the table below (table 3-3). Note that the ﬁgures in brackets are the 
change in percentage volume on expiration compared with inspiration. 
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Normal 6 Lung insp Lung exp Standard insp
Soft 
tissue 
exp
Bone 
insp Bone exp
Honeycombing (%) 38.8 42.5(+ 3.6) 6.0
8.5 
(+2.5) 9.6
13.7
(+4.1)
Reticulation (%) 1.2 16.9(+ 15.7) 4.6
23.7 
(+19.1) 2.3
26.9 
(+24.6)
Indeterminate (%) 1.1 24.6(+23.5) 4.7
49.6 
(+44.9) 5.9
44.7 
(+38.8)
Normal (%) 58.9 16.0(-42.8) 84.6
18.2
(-66.4) 82.2
14.8
(-67.4)
Normal 7 Lung insp Lung exp Standard insp
Soft 
tissue 
exp
Bone 
insp Bone exp 
Honeycombing (%) 39.6 35.5(-3.6) 5.3
5.1
(-0.2) 11.0
11.6
(+0.5)
Reticulation (%) 0.5 2.7(+2.3) 4.5
11.0
(+6.6) 1.4
7.1
(+5.7)
Indeterminate (%) 0.3 23.5(+23.1) 4.7
38.1
(+33.4) 2.9
48.3
(+45.4)
Normal (%) 60.1 38.3(-21.8) 84.6
45.8
(-38.9) 84.7
33.0
(-51.7)
Table 3-3 Eect of reconstruction algorithm and inspiration/expiration on normal scans 6 and 7. 
Figures in brackets indicate change in percentage lung volume between inspiration and expiration
For both scans, the class which was least aected by inspiration/expiration was 
honeycombing, with only a small change in the percentage of lung classiﬁed as 
honeycombing across all the reconstruction algorithms. The reticulation class was more 
sensitive to expiration/inspiration with the aect again seen across all reconstruction 
algorithms. The most sensitive class was indeterminate with a large increase seen on the 
expiratory scans. These eects are reﬂected in the amount of lung classiﬁed as normal 
for each reconstruction algorithm. Both standard and bone algorithms show over 82% of 
lung as normal on inspiratory scans whereas this drops to between 14 and 46% for 
expiratory scans.  
3.4 TESTING THE COMPUTER ALGORITHM AGAINST AN ABNORMAL CT SCAN 
MARKED UP BY A RADIOLOGIST
We will now present the results of testing the algorithm on the initial scan (patient 13) 
which was marked up by the radiologist for the purpose of training the algorithm. 
Although the radiologist had marked up only the right lung, the computer algorithm was 
used to analyse both the left and right lungs. A sample slice demonstrating the 
radiologist’s original mark-up and the computer generated mark-up side by side is 
show in ﬁgure 3-14.
Figure 3-14 Radiologist training segmentation (left) compared with automated computerised 
segmentation (right) on a single identical slice. Courtesy of Dr A Bhalerao
This shows that there is a similar spatial distribution of texture classiﬁcation for the 
computer and the radiologist but the computer algorithm shows more variability over a 
small area, consistent with it using smaller regions of interest (5 x 5 x 5 pixels) 
compared with the radiologist’s larger and variable sized (freehand) ROIs. The previously 
described edge artefact is again seen around the mediastinal vessels. 
Further comparison of the radiologist mark-up can be made by looking at principle 
components analysis (PCA) of the radiologist mark-up and computer classiﬁcation. 
Principle components analysis provides a visual demonstration of the Minkowski 
functional features which best distinguish between the dierent textural classiﬁcations 
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on a VOI by VOI basis.  Figure 3-15 shows the PCA analysis for the radiologist (left hand 
image) and computer (right hand image) for slice 266 (the same slice as in Figure 3-14). 
Figure 3-15  PCA analysis of the dierent textural classes in slice 266 of patient 13. The left hand 
image is from the radiologist mark up and the right hand image is from the computer mark up
From Figure 3-15 we can see the radiologist classiﬁcation shows more overlap of the 
reticulation, honeycombing and indeterminate classes compared with the computer. The 
normal mark-up appears to be the most robust feature, with tight clustering of the 
normal VOIs at the left hand side of the graph. In comparison, the computer 
classiﬁcation shows tighter clustering of the classes and less overlapping of the 
honeycombing and reticulation classes. It does show slightly more overlapping of the 
normal and honeycombed lung compared with the radiologist but this may be due to the 
edge segmentation artefact described earlier where normal lung at the edge of a slice 
may be mis-classiﬁed as honeycombing. There is also some uncertainty in the 
indeterminate class although this is less marked than for the radiologist mark-up. 
Another way of comparing the radiologist and computer classiﬁcation is to compare the 
classiﬁcation of all 5 x 5 x 5 VOIs in the right lung of patient 13. This data is shown in 
the following 2 x 2 tables (table 3-4 and table 3-5) where ‘true class’ represents the 
radiologist classiﬁcation, training set P represents the 3000 original training VOIs per 
classiﬁcation (total 12,000) and the testing set Q represents the remaining 26,919 ROIs 
which were not used for training. All ﬁgures are given as percentages.
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Class
Computer classiﬁcation
Honeycombing Reticulation Indeterminate Normal
Honeycombing
Radiologist
Classiﬁcation
Reticulation
Indeterminate
Normal
81.2 8.5 5.5 4.8
9.3 44.9 16.3 29.6
2.7 6.5 42.5 48.3
0.9 2.9 9.4 86.8
Table 3-4 Classiﬁcation of the computer output compared with the radiologist classiﬁcation on 
the training set (P)
Class
Computer classiﬁcation
Honeycombing Reticulation Indeterminate Normal
Honeycombing
Radiologist
Classiﬁcation
Reticulation
Indeterminate
Normal
65.2 18.4 8.5 7.9
17.4 27.7 23.2 31.7
4.0 10.9 26.6 58.5
2.2 4.5 18.3 75.0
Table 3-5 Classiﬁcation of the computer output compared with the radiologist classiﬁcation on 
the testing set (Q)
We can see that for the training set (P), there is an 81.2 % sensitivity for honeycombing, a  
44.9% sensitivity for reticulation, a 42.5% sensitivity for indeterminate lung and an 86.8% 
sensitivity for normal lung. As would be expected, the performance for the testing set 
(Q) is less good with 65.2% sensitivity for honeycombing, 27.7% sensitivity for 
reticulation, 26.6% sensitivity for indeterminate and 75.0 % sensitivity for normal lung. 
For both data sets, it is evident that honeycombing and normal lung show best 
agreement between radiologist and computer. 
3.4.1 Minkowski functional output
The ﬁgure below illustrates the Minkowski functional outputs from the whole of the 
right lung of subject 13 across the complete range of Hounsﬁeld Unit thresholds. It 
shows that normal and indeterminate categories do not show much separation in any of 
the MFs. Honeycombing is well separated across all the MF distributions but this 
separation varies according to the threshold. 
Figure 3-16 Minkowski functional distributions from the right lung of subject 13. Coloured 
curves represent the MF distributions for each texture classiﬁcation averaged over all VOIs in the 
right lung. Red = honeycombing, green = reticulation, blue = indeterminate, purple = normal. The 
black line represents the MF distribution for a single voxel of normal lung
3.5 CONCLUSION
In this chapter, we have discussed the output of the computer algorithm both in 
qualitative and quantitative terms. We have looked at some of the sources of variation in 
the classiﬁcation of lung texture by the computer algorithm including artefacts at the 
interface of dierent tissues, artefacts due to movement and artefacts due to 
gravitational eects. We have also looked at the inﬂuence of reconstruction algorithm 
and depth of breathing on classiﬁcation. Speciﬁcally, we have looked at outputs 
produced when the algorithm is tested on scans from patients with normal lungs and a 
single scan from a patient with pulmonary ﬁbrosis. We have looked at typical Minkowski 
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functional outputs from a whole scan and have used principle components analysis to 
study the power of discrimination of Minkowski functionals on a single slice. 
Classiﬁcation of the pulmonary ﬁbrosis scan has been compared with radiologist 
classiﬁcation over a total of 26,919 VOIs. 
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CHAPTER 4 - RESULTS PART 2: TESTING OF THE COMPUTER 
ALGORITHM ON PROSPECTIVELY RECRUITED PATIENTS
4.1 INTRODUCTION TO CHAPTER 4
In this chapter we will look at the characteristics of the 24 prospectively recruited 
patients with CFIP including demographics, pulmonary function tests, respiratory 
questionnaire scores and computerised analysis of the CT scans.
4.2 DEMOGRAPHICS
4.2.1 Age
The subjects ages ranged from 62 years to 84 years. The mean age at enrollment to the 
study was 73 years and 8 months and the median age was 74 years 6 months. 
4.2.2 Gender
The majority of patients were male (18 male patients and 6 female patients).
4.2.3 Smoking status
The majority of patients were ex-smokers with only 8 of 24 patients classifying 
themselves as ‘never smokers’. The mean exposure to cigarette smoke was 20.4 pack 
years (SD = 15.4 years). At the time of enrollment to the study none of the patients were 
current smokers or had smoked in the month before enrollment.
4.2.4 Sub-type of IIP
Five patients had undergone a lung biopsy for diagnosis. In one patient this showed 
desquamating interstitial pneumonia (DIP). For this patient, although a previous clinical 
scan had showed ground glass shadowing, the ﬁrst study scan was completely normal 
and therefore this patient was excluded from further analysis. Biopsy showed a UIP 
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pattern in two patients and ﬁbrotic NSIP in two patients. For the remaining patients 
without a lung biopsy, the conclusion of the regional interstitial lung MDT was used as 
the working diagnosis. Of the 19 patients who did not have a biopsy, eleven showed a 
typical UIP pattern on CT (according to the criteria in table 1-2); two were felt to have 
possible UIP; ﬁve were felt to have ﬁndings most compatible with NSIP and one was felt 
to have features of both NSIP and organising pneumonia. 
4.3 PULMONARY FUNCTION TESTS
Two patients were unable to perform baseline pulmonary function testing: one patient 
was too breathless and one patient found it too unpleasant an experience. This left 21 
patients with full pulmonary function and CT scan for analysis.
4.3.1 Spirometry
4.3.1.1 Forced expiratory value in 1 second (FEV1)
Baseline FEV1 ranged from 1.73 L to 2.55 L with a mean of 2.13 L and a standard 
deviation of 0.27 L. The percent predicted FEV1 ranged from 70.8% to 107.8% with a 
mean of 85.6 % and a standard deviation of 11.2 %
4.3.1.2 Forced vital capacity (FVC)
Baseline FVC ranged from 1.97 L to 3.82 L with a mean of 2.71 L and a standard 
deviation of 0.40 L. The percent predicted FVC ranged from 62.3% to 103.2% (mean 
83.4%, standard deviation 11.0%).
4.3.2 Gas transfer (DLCO)
The values for DLCO at baseline ranged from 1.83 mm.min-1.kPa -1 to 6.51 mm.min-1.kPa 
-1 (mean = 3.58, SD = 1.14). The percent predicted DLCO ranged from 23.8% (absolute 
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value = 1.83) to 85.1% (absolute value = 4.74) with a mean of 48.1% and a standard 
deviation of 16.6%. 
 
4.4 ST GEORGE’S RESPIRATORY QUESTIONNAIRE (STGRQ) SCORES
As previously discussed in Chapter 2, the highest possible total STGRQ score is 100 and 
the highest score for each of the domains (symptoms, activities or impacts) is also 100 
with a higher score indicating a greater degree of limitation. 
Total scores in the STGRQ ranged from 10 to 98 (mean = 47, SD = 23). Scores in the 
symptoms domain ranged from 11 to 95 (mean = 49, SD = 25). Scores in the impacts 
domain ranged from 4 to 100 (mean = 37, SD = 25) and scores in the activities domain 
ranged from 6 to 100 (mean = 59, SD = 28). This indicates a large spread in the 
distribution of STGRQ scores across all the domains and a wide range in the severity of 
patients symptoms, physical limitations and impairment in quality of life.  
4.5 COMPUTERISED CLASSIFICATION OF CT SCANS
The table below (table 4-1) shows the complete computerised classiﬁcation data for the 
23 patients including the CT calculated total lung volume and the CT calculated volume 
of honeycombing, reticulation, indeterminate and normal lung, both in millilitres and in 
percentage of the total lung volume. 
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Study ID CT total lung 
volume (ml)
CT 
honeycombi
ng (ml)
CT 
honeycombi
ng (%)
CT 
reticulation 
(ml)
CT 
reticulation 
(%)
CT 
indeterminat
e (ml)
CT 
indeterminat
e (%)
CT normal 
(ml)
CT normal 
(%)
1 6400 663 10 390 6 685 11 4663 73
2 4696 708 15 410 9 1013 22 2565 55
3 4620 456 10 507 11 1339 29 2318 50
4 4073 785 19 800 20 1788 44 700 17
5 4259 1346 32 429 10 975 23 1509 35
6 2037 901 44 507 25 544 27 85 4
7 4975 1130 23 412 8 752 15 2681 54
8 4637 1286 28 288 6 532 11 2531 55
9 3565 665 19 1195 34 1492 42 213 6
10 5356 2116 40 615 11 1122 21 1502 28
11 3499 720 21 615 18 862 25 1203 34
12 4272 502 12 990 23 1080 25 724 17
13 4015 1673 42 734 18 1084 27 525 13
14 4760 509 11 714 15 1644 35 1803 38
15 3680 489 13 684 19 510 14 1425 39
16 3730 1452 39 427 11 882 24 969 26
17 5240 669 13 392 7 1239 24 2941 56
18 4138 630 15 1179 28 1876 45 190 5
20 5903 3356 57 128 2 1098 19 3383 57
21 4003 1253 31 627 16 627 16 1829 46
22 4509 1017 23 444 10 745 17 2303 51
23 4117 1314 32 327 8 513 12 1963 48
24 4487 572 13 330 7 687 15 2898 65
Mean 
(SD)
4390
(884)
1088
(432)
26
(11)
519
(224)
13
(7)
1004
(408)
24
(10)
1779
(1149)
38
(20)
Table 4-1 Total lung volumes and computer classiﬁcation of the 23 prospectively recruited 
patients (note that there is no patient 19 as this subject was excluded due to a normal CT)
From this table we can see that the CT calculated lung volume ranged from 2037 ml to 
6400 ml (mean 4390 ml, SD 884 ml).
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The CT calculated volume of honeycombing ranged from 456 ml to 3356 ml (mean = 
1088 ml, SD = 432 ml) with the percentage of honeycombing ranging from 10 % to 57 % 
(mean = 26%, SD = 11%).
The estimated volume of reticulation ranged from 128 ml to 1195 ml (mean = 519 ml, 
SD = 224 ml) with the percentage of reticulation ranging from 2% to 34 % (mean = 13%, 
SD = 7%). 
The estimated volume of indeterminate lung ranged from 532 ml to 1788 ml (mean = 
1004 ml, SD = 408 ml) with the percentage of indeterminate lung ranging from 11 % to 
45 % (mean = 24%, SD = 10%).
The estimated volume of normal lung ranged from 85 ml to 4663 ml (mean =1779 ml, 
SD = 1149 ml) with the percentage of normal lung ranging from 4% to 73% (mean = 38%, 
SD = 20%).
Examples of the automatically classiﬁed scans are given below, showing examples of a 
patient with mild disease, a patient with moderately severe disease and a patient with 
advanced disease (Figures 4-1 to 4-3). 
Figure 4-1  An example of an axial slice from the least severely aected patient showing that the 
computer has correctly identiﬁed a tiny area of honeycombing in the para-vertebral region of the 
right lung (red) but has also erroneously classiﬁed central vessels as honeycombing
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Figure 4-2 An example of an axial slice from a moderately severely aected patient showing an 
area of established honeycombing in the posterior segment right upper lobe adjacent to the 
oblique ﬁssure (red) and areas of subtle reticulation (green). The large amount of indeterminate 
classiﬁcation (blue) is thought to be be due to the scan being relatively expiratory
Figure 4-3 An example of an axial slice from a patient with advanced disease showing extensive 
honeycombing (red) admixed with reticulation (green) with only small amounts of normal lung 
remaining
4.6 RADIOLOGIST VISUAL SCORING OF CT SCANS
The range of radiologists scores will be discussed in this section and comparisons 
between radiologists’ scoring and the computer ﬁbrosis score will be presented in the 
next chapter. Radiologist 1 (EH) scored all the scans, scoring 5 axial slices per patient 
(total of 115 slices). The range of honeycombing scores on a single slice for radiologist 1 
was between 0% and 85%. One patient was scored as having no honeycombing on any 
slices whilst the patient scored as having most honeycombing had percentage 
involvement of 15%, 50%, 50%, 70% and 85% on their ﬁve slices (cranial to caudal).  The 
range of reticulation scores on a single slice was between 0% and 45%. The most mildly 
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aected patient had a reticulation score of 5% on each slice and the most severely 
aected patient had scores of 35%, 20%, 15%, 10% and 60% (cranial to caudal). 
Radiologist 2 (RB) scored a subset of 40 slices and had a range of 0% to 60% for 
honeycombing and 5% to 50% for reticulation. Figure 4.4 shows an example slice which 
has was scored by the two radiologists. Radiologist 1 scored it as having 20% 
honeycombing whilst Radiologist 2 scored it as having 10% honeycombing. For the same 
slice, reticulation score was 10% for Radiologist 1 and 25% for Radiologist 2. This 
illustrates how it may be dicult for the radiologists to decide whether an abnormal 
pattern should be classed as honeycombing or reticulation. 
Figure 4-4 An example axial slice at the level of the carina where Radiologist 1 and 
Radiologist 2 scored the amount of honeycombing at 20% and 10% respectively and 
the amount of reticulation at 10% and 25% respectively
4.6 CONCLUSION
In summary, our group of prospectively recruited patients were largely male, ex-
smokers with an average age of 74, most of whom had a diagnosis of UIP or NSIP. They 
had relatively mild impairment of their FEV1 (mean = 85.6 % predicted) and relatively 
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mild impairment of FVC (mean = 83.4% predicted). Patients generally had more severe 
impairment of DLCO than FVC with a mean value of 48% predicted. The DLCO also showed 
a much larger range of values than either FEV1 or FVC. Scores in the St George’s 
Respiratory Questionnaire showed a wide variation between patients, both in terms of 
the total score and the individual domains. Equally, both the computerised and 
radiologist assessment of abnormal lung textures suggest a wide range in disease 
severity between patients. 
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CHAPTER 5 - RESULTS PART 3: RELATIONSHIPS BETWEEN THE 
MEASURED VARIABLES
5.1 INTRODUCTION
In this chapter we will explore the relationships between the computer ﬁbrosis score 
(CFS), the pulmonary function tests (TLC, FVC and DLCO) and the St George’s 
respiratory questionnaire. We will also compare the computer ﬁbrosis score and the 
radiologist ﬁbrosis score (RFS) and the inter-observer variability between two 
radiologists. Each set of results will be followed by a brief discussion of the meaning 
of the results with a full discussion presented in Chapter 6.
5.2 COMPARISON OF COMPUTER ESTIMATED LUNG VOLUME AND TLC
The computer calculated total segmented lung volume was compared with the total 
lung capacity as measured on pulmonary function tests. The graph below (Figure 5-1)  
shows the correlation between the two measurements. The data for this graph 
excludes the two patients who were unable to perform lung function tests. 
We can see that there is a very good correlation between the two measurements with 
an R-value of 0.85 (p<0.001). 
Figure 5-1 Linear regression showing correlation between computer calculated lung volume 
and TLC
A Bland-Altman plot was created to examine whether there was any systematic 
dierence between the computer calculated lung volume and the TLC (Figure 5-2). 
Please note that the data are the same as in Figure 5-1. 
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Figure 5-2 Bland-Altman plot illustrating the dierence between the computer calculated lung 
volumes and TLC
This plot illustrates the fact that the mean dierence between the computer 
estimated lung volume and the TLC is + 561 ml i.e. the computer tends to estimate 
the lung volume as larger than the TLC measurement. The conﬁdence interval for the 
mean is +345 ml to +777 ml. The most likely explanation for the discrepancy is that 
the computer calculated CT lung volume includes the pulmonary interstitium and 
blood vessels which typically make up approximately 10% of the pulmonary 
parenchyma (Cressoni et al., 2013, van Rikxoort and van Ginneken, 2013). Therefore 
it would be expected that the CT calculated volume is approximately 10% larger than 
the TLC. There are several other variables that may contribute to the dierence 
between these measurements including: areas of honeycombing which do not 
ventilate will reduce the TLC; areas of air-trapping will reduce the TLC; depth of 
inspiration will aect the CT calculated lung volume; errors in segmentation will 
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aect the CT calculated lung volume. There is an outlier in the bottom left hand 
corner of the plot (circled in blue). This was a patient with TLC of 2910 ml and CT 
calculated lung volume of 2037 ml and is point situated furthest to the left on Figure 
5-1. The discrepancy is thought to be due to the fact that the patient’s CT was quite 
expiratory, reducing the apparent lung volume on CT. 
5.3 THE RELATIONSHIP BETWEEN COMPUTER ESTIMATED CT FIBROSIS AND DLCO
Linear regression was used to compare the CT calculated ﬁbrosis score 
(honeycombing plus reticulation) and the percentage predicted DLCO. The patients are  
the same as in Section 5.2. The graph below (Figure 5-3) illustrates that there is a 
moderately strong negative correlation between the two variables with an R-value of 
-0.65 (p=0.001).
Figure 5-3 Linear regression showing the correlation between computer calculated 
percentage ﬁbrosis and DLCO. Outliers are circled. 
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We can see that there are two outliers who have a higher percent-predicted DLCO than 
would be expected from the percentage of ﬁbrosis measured on CT. The ﬁrst outlier 
(Patient 1 - circled in blue) is the subject with both the lowest percentage of ﬁbrosis 
on CT and the highest DLCO. Since we have a lack of any other data-points with DLCO 
more than 66%, there is more uncertainty about the shape of the graph near the 
beginning of the x-axis. It may be that the best ﬁt-line for the plot is actually a 
logarithmic curve and patients with lower amounts of ﬁbrosis on CT have 
proportionally greater values of DLCO  than patients with higher amounts of ﬁbrosis. 
Further investigation of this relationship would require conﬁrmation by testing in a 
larger patient group with more mildly aected patients. Alternatively, either the CT 
ﬁbrosis or the DLCO may have been under or over-estimated due to error in either 
measurement. Visual inspection of the classiﬁcation of this patient shows that 
classiﬁcation is good but due to this patient having very little honeycombing, the 
erroneous classiﬁcation of edge voxels as honeycombing will contribute a signiﬁcant 
proportion of this patients total ﬁbrosis and may partly explain the higher DLCO than 
would be expected for the estimated amount of ﬁbrosis. The second outlier (Patient 
12 - outlined in red) had a large amount of lung which was erroneously classiﬁed as 
honeycombing on CT. This is thought to be due to the scan being considerably 
noisier than the other scans due to the patient’s relatively large body habitus. To test 
this theory, the algorithm was re-run on thicker slice reconstructions from the same 
patient (1.25 mm vs 0.625 mm). This reduced the amount of lung wrongly classiﬁed 
as honeycombing from 44% to 34%. An example slice is shown below (Figure 5-4).
Figure 5-4 Example from Patient 12 showing a greater percentage of honeycomb 
classiﬁcation (red) in the left-hand thin (0.625 mm) slice compared with the thicker (1.25 mm) 
slice on the right
5.4 THE RELATIONSHIP BETWEEN COMPUTER ESTIMATED CT FIBROSIS AND FVC
Linear regression was used to compare computer estimated CT ﬁbrosis and percent 
predicted FVC (Figure 5-5). The patients are the same as in the previous section.
Figure 5-5 Linear regression showing the correlation between computer calculated 
percentage ﬁbrosis and FVC
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We found a moderate correlation between the two variables with an R-value of -0.54 
(p=0.01). The strength of correlation is not quite as good as for CT ﬁbrosis and DLCO 
(Section 5.3). There are a number of possible explanations for this. Firstly, our 
patients had quite a narrow range of percent predicted FVC values, ranging from 62% 
to 103%. In fact, nearly half the patients had values above 80% which can be 
considered within the normal range. This means that FVC is likely to be a less 
sensitive measure of lung disease in our patient group and may be more aected by 
random variation (noise). Ideally more subjects with a greater range of FVC values 
would be needed to better understand the relationship between the CT ﬁbrosis score 
and FVC. 
5.5 RELATIONSHIP BETWEEN CT FIBROSIS AND THE ST GEORGE’S RESPIRATORY 
QUESTIONNAIRE
Data was available for all 23 patients. Linear regression analysis was performed to 
assess the correlation between CT ﬁbrosis and the total St George’s score and 
between CT ﬁbrosis and the individual domains of the St George’s score, namely 
‘symptoms’, ‘impacts’ and ‘activities’. As shown in Figure 5-6, there was no 
signiﬁcant correlation between CT ﬁbrosis and either the total St George’s score 
(R=0.31, p = 0.17) or the individual components relating to symptoms (R = 0.27, p = 
0.24), impacts (R = 0.26, p = 0.25) or activities (R = 0.36, p = 0.11). There are several 
possible reasons for this: the St George’s Respiratory Questionnaire was originally 
designed for use in patients with COPD and therefore some of the questions, for 
example about wheeze, are less relevant to patients with CFIP; the questionnaire 
relies on patients recall of their symptoms over the previous 3 months and therefore 
their answers may be aected by recall bias; for the questions in the activity and 
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impacts domains patients may ﬁnd it dicult to judge whether their limitations are 
due to their respiratory disease or aected by other co-morbidities - this is likely to 
be especially relevant in our relatively elderly patient group. Also, as a general rule, 
questionnaire studies normally need large numbers of patients to show meaningful 
results due to the subjective nature of this type of measurement tool. 
Figure 5-6 Relationship between CT ﬁbrosis and the St George’s Respiratory Questionnaire
5.6 RELATIONSHIP BETWEEN DLCO AND THE ST GEORGE’S RESPIRATORY 
QUESTIONNAIRE
Linear correlation did not show any signiﬁcant relationship between DLCO and either 
the total score in the St George’s Respiratory Questionnaire (R = 0.33, p = 0.14) or 
the individual St George’s domains of symptoms (R = 0.24, p = 0.29), activities (R = 
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0.37, p = 0.10) or impacts (R = 0.35, p = 0.12) as shown in Figure 5-7 below. It is 
likely that this lack of correlation is due to similar reasons as the lack of correlation 
between CT ﬁbrosis and STGRQ.
Figure 5-7 Relationship between DLCO (percent-predicted) and the St George’s Respiratory 
Questionnaire
5.7 RELATIONSHIP BETWEEN FVC AND THE ST GEORGE’S RESPIRATORY 
QUESTIONNAIRE
Linear correlation did not show any signiﬁcant correlation between FVC and either the 
total STGRQ score (R = 0.30, p = 0.19) or the activities (R= 0.21, p = 0.36) or impacts 
(R = 0.32, p = 0.15) domains. There was a weak association shown between the FVC 
and the symptoms domain (R = 0.46, p = 0.04) but this result should be interpreted 
with caution, due to the small numbers of patients. Similar reasons to those 
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described in section 5.5 and section 5.6 are likely to explain the lack of association 
between FVC and the responses to the STGRQ.
Figure 5-8 Relationship between FVC (percent-predicted) and the St George’s Respiratory 
Questionnaire
5.8 RELATIONSHIP BETWEEN RADIOLOGIST FIBROSIS SCORE AND COMPUTER 
FIBROSIS SCORE
The correlation between radiologist visual score and computer calculated ﬁbrosis 
score was analysed for the 23 patients scored by Radiologist 1 (EH). Five slices per 
patient were visually scored as previously described in the Methods section. This 
produced a total of 115 slices for which a radiologist visual score and computer 
ﬁbrosis score was available. There was a moderate correlation between the 
radiologist ﬁbrosis score (reticulation plus honeycombing) and the computer ﬁbrosis 
score (reticulation plus honeycombing) with an R-value of 0.61 (p<0.0001) as shown 
in Figure 5-9. 
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Figure 5-9 Relationship between the radiologist ﬁbrosis score and the computer ﬁbrosis score
Figure 5-9 illustrates a number of aspects of the data. Firstly, the radiologist score 
has been performed to the nearest 5% since it is not feasible to score more accurately 
than this and therefore there is clustering of the data along the x-axis. Secondly, 
because most of the patients in the study have relatively mild disease, there is 
clustering of data points towards the origin. Apart from the inherent dierences 
between the continuous numbers provided by the computer and the discrete bins of 
the radiologist scoring, there are several other reasons for potential discrepancies 
between the radiologist and computer scoring including: the radiologist visual 
‘guestimate’ of percentage involvement is prone to error which would be expected to 
be at least 5% either way; the radiologist is able to mentally dismiss artefact such as 
breathing or image noise which the computer frequently mis-classiﬁes as pathology; 
the computer has not been trained to identify certain patterns such as ground glass 
opacity or consolidation which it must then assign to another category. Such 
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alternative patterns may be classiﬁed as ﬁbrosis by the computer leading to a falsely 
inﬂated ﬁbrosis result. In order to assess whether there was a systematic over- or 
under-estimation of the computer compared with the radiologist, we generated a 
Bland-Altman plot (Figure 5-10 below). 
Figure 5-10 Bland-Altman plot illustrating the dierence between the computer calculated 
ﬁbrosis score and the radiologist estimated ﬁbrosis score
As can be seen from ﬁgure 5-10, the computer ﬁbrosis score tends to be higher than 
the radiologist ﬁbrosis score with a mean dierence of +12.4% (95% conﬁdence 
interval = +9.1 to +15.8%). Most of this over-estimation can be accounted for by the 
edge artefact described earlier whereby the computer falsely assigns pixels at the 
periphery of the lung to the honeycombing class (accounting for a mean of 7.7% of 
erroneous honeycombing on the control scans) and by blood vessels which are 
erroneously classiﬁed as honeycombing. Other potential reasons include other 
artefacts such as breathing artefact and classiﬁcation of vessels or airways as ﬁbrotic 
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lung; mis-classiﬁcation of emphysema or atelectasis as ﬁbrosis and visual under-
estimation by the radiologist.
Some clustering of data points is seen near the origin of the graph on the left. This 
may partly be explained by the fact that the potential to under-estimate disease is 
more limited when there are smaller amounts of ﬁbrosis since it is not possible to 
have a ﬁbrosis score of less than 0%. Whilst a score of more than 100% is also 
impossible, very few slices had such large amounts of ﬁbrosis. 
In order to assess whether the computer ranking of severity is similar to the 
radiologist ranking of severity, even if there was a systematic over-estimation of 
ﬁbrosis by the computer or under-estimation by the radiologist, a Spearman’s rank-
order correlation was performed. This showed a correlation co-ecient of 0.568 
which was signiﬁcant at the 0.01 level and indicates a moderate correlation between 
the radiologist and computer ﬁbrosis scores. 
5.9 INTER-OBSERVER VARIABILITY BETWEEN RADIOLOGIST’S VISUAL SCORING
For 8 of the CT scans, scoring was performed by two radiologists - Radiologist 1 who 
performed the scoring on all 23 patients as presented in section 5.8 and Radiologist 2 
who performed scoring on 8 patients. Therefore, at 5 slices per patient, there were 40 
slices which were scored by both radiologists. 
Linear regression analysis was performed to compare the two radiologists scoring for 
honeycombing, reticulation and total ﬁbrosis (honeycombing plus reticulation). As 
shown in Figure 5-11, there was excellent agreement between the radiologists for 
honeycombing (R=0.86; p < 0.001) but less good agreement in terms of reticulation 
(R = 0.44; p < 0.01). This is not surprising as honeycombing usually has discrete 
margins, often lying adjacent to normal lung and is therefore fairly straightforward to 
visually assess in terms of area aected. However, linear reticulation typically aects 
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the sub-pleural lung with linear densities interspersed with more normal lung and 
with an ill-deﬁned boundary between normal and abnormal lung. Interestingly, total 
ﬁbrosis scores showed even better agreement than honeycombing with an R-value of 
0.90 (p<0.001) suggesting that some lung which was classiﬁed as honeycombing by 
Radiologist 1 was classiﬁed as reticulation by Radiologist 2 and vice versa. Intraclass 
correlations were also used to compare Radiologist 1 and Radiologist 2. This gave an 
ICC of 0.94 for total ﬁbrosis, 0.90 for honeycombing and 0.60 for reticulation which 
according to Landis et al, represents ‘near perfect’ agreement for total ﬁbrosis and 
honeycombing and ‘moderate’ agreement for reticulation (Landis and Koch, 1977). 
Figure 5-11 Comparison of radiologists scores for total ﬁbrosis, honeycombing, and 
reticulation for 40 axial CT slices
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5.10 CHAPTER SUMMARY
In summary, we have now looked at the correlations between the computer estimated 
lung volume and the total lung capacity (TLC); between the CFS and pulmonary 
function tests (DLCO and FVC); between the CFS and scores on the St George’s 
Respiratory Questionnaire; between pulmonary function tests and the St George’s 
Respiratory Questionnaire; between the visual scoring of radiologist 1 and the 
computer ﬁbrosis score and between the two radiologists’ scoring. 
CHAPTER 6: DISCUSSION
6.1 INTRODUCTION TO CHAPTER
As previously discussed, the chronic ﬁbrosing idiopathic pneumonias (CFIPs) are 
challenging diseases with no deﬁnite aetiology and with a poor prognosis. The 
commonest CFIP, which also has the worst prognosis, is idiopathic pulmonary ﬁbrosis. 
Recently, new pharmacological treatments for this disease have become available (King 
Jr et al., 2014, Noble et al., 2011, Richeldi et al., 2014) but still have a relatively small 
eect on disease progression. They are also very expensive and therefore it is important 
to ensure they are being used on patients who are likely to beneﬁt and to consider 
stopping treatment if it is ineectual. Measuring disease severity at diagnosis and over 
time is important for determining treatment decisions and for assessing the eect of 
new therapeutic agents. Because new treatments are likely to have relatively small 
eects on disease severity an accurate and reproducible measurement is essential. A 
recent observational study of patients with CFIP who had two CT scans performed one 
year apart and were not receiving any interventional treatment (Yoon et al., 2013) 
showed that there was only a 1.6% change in disease severity over the year, as assessed 
by two radiologists, which is within the range of measurement error. Another potential 
role for CT is in predicting prognosis in people with CFIP - both visual assessment and 
quantitative indices of ﬁbrosis have shown promise in this area (Best et al., 2008, Edey et 
al., 2011, Oda et al., 2014, Maldonado et al., 2014). In terms of measuring severity, CT 
has the advantage of providing a non-invasive and quick method for demonstrating the 
volume of disease as a percentage of the total lung volume. Whilst patients with 
signiﬁcant lung disease may struggle to perform pulmonary function tests, almost all 
patients are able to tolerate a CT. CT also has the advantage of being able to provide 
spatial information on disease extent and can quantify the contribution of dierent 
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disease pathologies such as UIP and emphysema which often co-exist (Jankowich and 
Rounds, 2012). 
To date, visual assessment has been the mainstay of assessing disease extent on CT and 
in the clinical situation is usually limited to a verbal description of disease severity such 
as mild, moderate or severe. Attempts to develop a more formal method of visually 
assessing disease severity have been made, typically using a semi-quantitative scoring 
system or a visual estimation of aected lung (Goh et al., 2008, Edey et al., 2011). 
However, such techniques are time consuming, prone to imprecision and limited by 
inter and intra-observer variability. Moreover, they are not practical for assessing the 
hundreds of slices generated by multi-detector volumetric CT. As a consequence, visual 
quantiﬁcation techniques have not been adopted outside of the research setting. 
An automated computerised approach to quantifying disease therefore has several 
potential advantages, particularly in terms of speed and reproducibility. Various 
attempts have been made to develop such methods but most studies have been 
retrospective and therefore have several biases including patient selection, use of 
dierent models of CT scanner and use of dierent CT algorithms, to which quantitative 
analysis is highly susceptible (Rosas et al., 2011, Uchiyama et al., 2003, Maldonado et 
al., 2014, Bartholmai et al., 2013, Yoon et al., 2013). 
The purpose of the current thesis was to develop and test a new computer algorithm for 
the assessment of disease severity on CT using a speciﬁc measure of textural geometry 
known as Minkowski Functionals. In previous chapters we have discussed the need for 
novel methods of measuring lung abnormality on CT in the CFIPs and described the 
methodology for developing our computer software including its training and testing. 
We have examined the performance of the computer algorithm on a series of normal 
scans and on scans from 24 prospectively recruited patients with CFIP. The performance 
of the computer algorithm has been assessed by comparing the computer estimated 
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ﬁbrosis score (CFS) with a radiologist estimated computer score (RFS) and by comparing 
the CFS with pulmonary function tests and with a symptom and activities questionnaire 
(St George’s Respiratory Questionnaire). We will now discuss our results in the light of 
previous studies and draw conclusions about the meaning of our results, including the 
limitations of our ﬁndings. 
6.2. DEVELOPMENT OF THE COMPUTER ALGORITHM
The ﬁrst challenge when developing an automated lung analysis algorithm is to separate 
the lung tissue from other structures which do not need to be analysed such as the chest 
wall, mediastinum, large airways and blood vessels. The separation of the lung from the 
chest wall, mediastinum and large blood vessels is a relatively straightforward task in 
patients with normal lung owing to the large dierence in density between aerated lung 
and other soft tissue structures. However, it has proven much more challenging in 
interstitial lung disease. For example Meng et al (Meng et al., 2012) tested a basic 
adaptive thresholding segmentation method on 2768 CT scans obtained from a number 
of databases including the Lung Image Database Consortium which includes patients 
with interstitial lung disease (Armato III et al., 2007). They found that 16% of the 
interstitial lung disease scans encountered segmentation problems, typically excluding 
the diseased lung from the calculated lung volume. Wang et al (Wang et al., 2009) 
developed a more successful method using a combination of thresholding and textural 
analysis. The method was tested on 45 scans with moderate to severe interstitial lung 
disease in which an expert manually traced the lung edge, on three slices per patient, to 
provide the reference standard. They measured the percentage overlap between the area  
segmented by the radiologist and the automatically segmented area and found a mean 
agreement of 96% (range of 90 - 99%). Although this is an impressive success rate, it 
should be noted that only three slices were assessed and the diaphragmatic lung was 
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not assessed, which is often the most dicult area to segment. In addition, the 
maximum discrepancy of 10% is not insigniﬁcant. Such a level of discrepancy would be 
enough to make a considerable impact on the estimation of the extent of abnormal lung 
and may limit assessment of small degrees of change. We found that our segmentation 
method was robust and reliable even when assessing scans with severe interstitial lung 
disease but encountered problems when there was breathing artefact, particularly at the 
lung bases, and when there was excessive image noise such as in larger patients. 
It should also be mentioned that we have only segmented out the larger, more central 
airways and blood vessels from the lung volume. This was a conscious decision as there 
is a risk when segmenting the smaller peripheral airways and blood vessels that adjacent 
lung parenchyma will also be removed. This is a particular concern in interstitial lung 
disease which preferentially tends to aect the outer, pleural-based lung where smaller 
vessels are found. The downside of our approach is that it will lead to the classiﬁcation 
of some smaller airways and blood vessels as diseased lung. 
Another important aspect of our software development was the training of the 
algorithm. We trained our algorithm using regions of interest marked up by a single 
radiologist on a single CT scan with the identiﬁcation of 4 categories of abnormality - 
honeycombing, reticulation, normal and indeterminate lung. The training scan was 
chosen to be representative of the four lung classiﬁcations and to have a range of 
disease extent (mild, moderate and severe) within the same scan. A total of 38,919 ROIs 
were generated from the radiologist’s manual segmentation and a sample of 12,000 5 x 
5 x 5 pixel VOIs were randomly selected from this total to train the algorithm. In 
contrast, in the paper by Zavaletta et al (Zavaletta et al., 2007), the CALIPER (Computer-
Aided Lung Informatics for Pathology Evaluation and Rating) software was trained using 
14 scans with representative VOIs which were determined by ‘experts’ to contain at least 
70% of one of the following categories: honeycombing, reticulation, ground glass, 
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emphysema and normal lung. It is not speciﬁed in the paper how many radiologist 
readers were used or why they were considered to be experts. Despite training the 
algorithm to detect ground glass and emphysema, their test CT datasets (n=4) did not 
contain either of these abnormalities and therefore performance in this area could not 
be assessed. They did not have an indeterminate classiﬁcation. The use of this 
indeterminate or ‘near-normal’ category in our study was designed to allow the 
categorisation of areas of subtle disease which could represent a pre-clinical or 
potentially reversible stage of pathology. Honeycombing and reticulation in UIP are 
believed to be irreversible and not amenable to pharmaceutical treatment (Müller et al., 
1987) although reticular opacities in NSIP do have the potential to resolve (Nishiyama et 
al., 2000). Therefore when assessing new potential therapeutic treatments, identiﬁcation 
of a pre-cursor to reticulation or honeycombing is desirable. The current study is 
insucient to establish whether this ‘near-normal’ lung is important but future studies 
could be performed to address this. 
Our algorithm has a number of limitations. Firstly, we did not train the algorithm to 
identify GGO or emphysema due to a lack of representative ROIs in our patient 
population. Therefore, our algorithm may mis-classify emphysema or ground glass as 
other abnormalities such as honeycombing or reticulation, falsely increasing the volume 
of these abnormalities. Most of our patients did not have signiﬁcant emphysema and 
therefore the size of error is probably small but this may not be the case in other patient 
groups. 
The fact that the training VOIs were provided by a single radiologist is a potential 
limitation of our study. Zavaletta et al (Zavaletta et al., 2007), in their study using the 
CALIPER software, describe how their test scans, which were marked up by 3 dierent 
radiologists, showed considerable variation in the areas considered to be normal or 
reticulation. It is also evident that three of their CT scans (datasets 1-3) contained very 
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little honeycombing and would therefore be considered to have relatively mild disease. 
Only the scan labelled ‘dataset 4’ contained a signiﬁcant percentage of honeycombing 
and much of this looks to have been mis-classiﬁed, judging by the example of 
segmentation presented in their paper. In 2014, Maldonado (Maldonado et al., 2014) 
presented further work using an updated version of CALIPER in a study looking at 
interval progression of interstitial lung disease in a retrospective study of 55 patients 
with at least 2 scans spaced between 3 and 15 months apart. The CALIPER algorithm was 
trained using VOIs from the scans of 14 patients from the Lung Tissue Research 
Consortium (LTRC) (Armato III et al., 2007). From these scans 4 radiologists 
independently labelled ROIs as emphysema, ground glass, honeycomb, normal or 
reticular densities with the proviso that at least 70% of the VOI should be composed of a 
single class. VOIs were only selected for training purposes if there was consensus on the 
classiﬁcation from all 4 radiologists. This resulted in the following number of training 
VOIs: emphysema (80), ground glass (150), honeycomb (187), normal (265), reticular 
densities (294). The CALIPER software uses VOIs of 15 x 15 x 15 pixels whereas we use 
VOIs of 5 x 5 x 5 pixels. We chose the smaller VOIs because we found that it allowed 
greater accuracy on our thin-slice acquisitions. We therefore used a considerably larger 
number of smaller ROIs in training our algorithm. Interestingly, it appears that texture-
based methods may not need huge numbers of training ROIs/VOIs. The texture-based 
method of Lee et al (Lee et al., 2009) used a training dataset comprising 63 severe 
emphysema ROIs, 65 mild emphysema, 70 bronchiolitis obliterans and 67 normal lung. 
Despite not being trained on interstitial lung disease, this method formed the basis of 
the AQS software which was successfully used by Yoon et al (Yoon et al., 2013) to assess 
for serial changes in CFIP on scans performed 1 year apart. 
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6.3  LESSONS LEARNT FROM THE ANALYSIS OF NORMAL SCANS
Several important points can be learnt from the analysis of the normal scans, mostly in 
terms of sources of error in the computer algorithm, as follows:
1) Edge artefact: it is apparent that there is a mis-classiﬁcation at the edge of the lung 
volume, where the lung abuts the chest wall, and where normal lung is sometimes mis-
labelled as honeycombing or reticulation. This is consistent in that it aects all scans but 
is much more pronounced when using the lung algorithm. The 2014 paper by 
Maldonado et al (Maldonado et al., 2014) also shows a similar artefact in their Figure 2 
where the strip of lung at the boundary between lung and chest wall has been mis-
classiﬁed as normal whereas the rest of the lung in the slice of interest shows 
honeycomb change. This artefact is not alluded to in the paper but is consistent with a 
boundary phenomenon. 
2) Choice of algorithm: we have demonstrated that the choice of reconstruction 
algorithm has a signiﬁcant inﬂuence on the classiﬁcation of lung texture. For example 
we found that on average, 37% of a normal scan was mis-classiﬁed as honeycombing on 
the lung algorithm whilst only 6% on average was mis-classiﬁed on the standard 
algorithm. A phantom study looking at the best reconstruction algorithm for assessing 
ILD, performed as a pre-cursor to the Lung Tissue Research Consortium project, was 
performed by Zhang et al using the American College of Radiologist’s ‘CT Image Quality 
Phantom Model 464’ (Zhang et al., 2008). This phantom is designed to measure multiple 
aspects of the CT image including CT number accuracy, high and low contrast resolution 
and image noise. They found that the GE ‘bone’ algorithm and the Siemens ‘B46f’ 
algorithm were the best algorithms in terms of providing high enough spatial resolution 
for clinical use as well as preserving CT number accuracy. Maldonado et al (Maldonado 
et al., 2014) used the bone algorithm for their study using the CALIPER software, 
presumably because the software had been trained on LTRC scans. We conclude that it is 
essential that all studies of automated quantiﬁcation in IIP provide explicit details of the 
algorithm used, something which is not always done.
3) Eect of inspiration: we examined the eect of inspiratory volume on texture analysis 
of two normal scans which had been obtained in both full inspiration and full expiration 
and found that degree of inspiration had a dramatic eect on the amount of lung 
classiﬁed as indeterminate and a signiﬁcant eect on the amount of lung incorrectly 
classiﬁed as reticulation but little eect on the amount of lung incorrectly classiﬁed as 
honeycombing. This highlights the importance of ensuring scans are performed in full 
inspiration. 
The important lessons learnt from the analysis of normal scans should inform the 
interpretation of the results from the pathological scans. To our knowledge, there have 
been no previous studies of the use of a texture-based lung analysis algorithm on CT 
scans of normal lungs which we would argue is a fundamental aspect of assessing any 
new algorithm. 
6.4 SCANS FROM PROSPECTIVELY RECRUITED PATIENTS
6.4.1. General observations
As expected, it was evident that issues that caused problems with normal scans also 
caused problems with pathological scans, including ‘image noise’ (particularly related to 
increased patient BMI) and ‘breathing artefact’. Linear streak artefact which is seen in 
low dose scans are particularly problematic for texture based quantiﬁcation as they can 
mimic reticulation (Coxson, 2013). This was more of a problem with the scans of the 
prospectively recruited patients than with the normal scans due to the reduced dose 
protocol used in the QUIC scans. 
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6.4.2 Comparison of computer-estimated ﬁbrosis and radiologist-
estimated ﬁbrosis
We used two methods to assess the accuracy of the computer algorithm compared with
radiologist assessment, as follows:
1) In the ﬁrst experiment, we compared the computer output with radiologist manual 
segmentation on a region by region basis using a single CT scan. This data was 
presented in Chapter 3 and showed that on a training set of 12,000 ROIs, the computer 
had a sensitivity of 81.2% for identiﬁcation of honeycombing, 86.8% sensitivity for 
identiﬁcation of normal lung, 44.9% sensitivity for reticulation and 42.5% sensitivity for 
indeterminate lung. The computer performed less well with classiﬁcation on the testing 
set of 26,919 ROIs with sensitivity of 65.2% for honeycombing, 75.0 % sensitivity for 
normal lung, 27.7% sensitivity for reticulation and 26.6% sensitivity for indeterminate. 
Therefore, the computer is most accurate at distinguishing normal lung from abnormal 
lung and within the abnormal lung, is most accurate at classifying honeycombing 
compared with the other textures. There are several potential reasons for this: a) the 
results are likely to reﬂect the radiologist’s conﬁdence for the dierent classes during 
the preparation of the training data; b) whereas honeycombing is easily distinguished 
from normal lung by both radiologist and computer, the boundary between coarse 
reticulation and honeycombing is often less clear; c) the boundary between 
indeterminate and normal lung, by the very deﬁnition of the indeterminate class, is likely 
to be blurred. Of note, most of the honeycombing that was wrongly classiﬁed was 
classiﬁed as reticulation, which is likely to represent a milder stage of the same ﬁbrotic 
process. It could therefore be argued that total ﬁbrosis is a more important metric than 
individual features of ﬁbrosis, such as honeycombing and reticulation. 
Only a few previous studies have directly compared computer classiﬁcation of lung 
texture with radiologist classiﬁcation and only one (Uchiyama et al) has looked at the 
sensitivity of computer versus radiologist on a region-by-region basis rather than on a 
slice-by-slice or lobar basis (Uchiyama et al., 2003). Uchiyama examined 315 single 
non-spiral slices from 105 patients with 3 radiologists labeling irregular ROIs as 
reticulation, nodular, honeycomb, emphysema, consolidation, non-speciﬁc or other 
(includes bulla, pleural thickening and atelectasis). They compared radiologist 
classiﬁcation with a computer algorithm based on an artiﬁcial neural network. For the 
ROI analysis, they looked ﬁrst at regions where all 3 radiologists agreed on the texture. 
In this case, the computer had 100% sensitivity for honeycombing, 100% sensitivity for 
reticulation and 88% sensitivity for normal lung. It should be noted that there were only 
15 reticulation ROIs. They also performed a separate analysis where they looked at 
whether an ROI was classiﬁed as abnormal or normal. For this analysis they found that 
the computer had 97% sensitivity for abnormal lung if all 3 radiologists agreed the ROI 
was abnormal but this dropped to 85% if there was discrepancy between radiologists. 
They performed a third analysis on a slice-by-slice basis, this time looking at whether 
the radiologist and computer classiﬁed the whole slice as normal, abnormal or 
indeterminate. For slices classiﬁed by the radiologist as normal the computer classiﬁed 
that slice as normal 84% of the time and for slices classiﬁed by the radiologist as 
abnormal, the computer classiﬁed them as abnormal 90% of the time. On the other 
hand, if the radiologist classiﬁed the slice as indeterminate, then the computer classiﬁed 
it as normal 53% of the time and abnormal 47% of the time. Therefore, from both our 
ﬁndings and those of Uchiyama et al, we can conclude that: honeycombing and normal 
lung are most accurately identiﬁed by the computer; that computers using artiﬁcial 
neural network methods are highly sensitive to training data; and that both computers 
and radiologists struggle with ‘indeterminate’ lung which may represent an overlap 
between other categories. 
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2) The second method we used to validate the computer output was to prospectively 
compare it with radiologist visual scoring of multiple scans on a slice by slice basis with 
radiologist scoring of lung abnormalities to the nearest 5%. This was done using 5 slices 
for each of 23 patients (total of 115 slices). This method of comparison cannot be as 
spatially precise as the VOI-based method but it would be impractical to expect 
radiologists to manually segment the whole of a volumetric scan into all its dierent 
textural classiﬁcations. For comparison of the radiologist and computer in this method 
we decided to compare total ﬁbrosis (reticulation plus honeycombing) rather than 
looking at honeycombing and reticulation separately. This decision was made due to the 
overlap that these classes had demonstrated in the ﬁrst method described and because 
we felt that it was more important to distinguish diseased lung from non-diseased lung 
rather than to distinguish between dierent features of ﬁbrosis. 
Linear regression analysis was performed to examine the agreement between the 
radiologist total ﬁbrosis score and the computer total ﬁbrosis score. This showed a 
moderate correlation between the two scores with an R-value of 0.61 (p<0.0001) and 
Spearman’s rank-order correlation co-ecient of 0.568 (p < 0.01). It is inevitable that 
there will never be perfect correlation with this method since the radiologist is scoring to 
the nearest 5% and the computer is measuring on a continuous scale. In addition, the 
radiologist visual scoring will always involve a margin of error due to the nature of the 
method, which is a value judgement. We have also identiﬁed a number of inaccuracies in 
the computer method caused by problems such as image noise; artefact from patient 
breathing, diaphragm motion and cardiac motion; problems segmenting airways and 
blood vessels and the edge artefact that was described earlier. It is also worth noting 
that the computer processes the data in terms of 3D volumes (5 x 5 x 5 pixel VOIs) 
whereas the radiologist is making their assessment on 2D slices. Nevertheless the 
degree of correlation is reasonable, particularly given that the computer has only been 
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trained on data from a single subject and by a single radiologist. Iterative training with 
new datasets could improve this performance. 
6.4.3 Comparison of computer estimated ﬁbrosis and pulmonary 
function tests
In the previous chapter we looked at the correlation between the computer ﬁbrosis score 
(CFS) and pulmonary function tests, speciﬁcally the forced vital capacity (FVC) and the 
diusion capacity of carbon monoxide (DLCO). These lung function measures were 
chosen since they are the most frequently used clinical measures of CFIP and because 
changes in these measures are the most frequent end-points in clinical trials involving 
CFIP patients (Raghu et al., 2012). We found that there was a good correlation between 
CFS and DLCO with an R-value of -0.65 (p = 0.001) despite two outliers. We also found a 
slightly lesser correlation between CFS and FVC with an R-value of -0.54 (p = 0.01).
As previously discussed, several factors may inﬂuence the CT ﬁbrosis score including 
segmentation errors, image noise and movement artefact. Some of these errors, such as 
the erroneous honeycombing seen at the edge of scans, will have a proportionally larger 
eect on the more mildly aected patients. Factors which may aect the DLCO 
measurement include the patient’s haemoglobin concentration, current smoking status, 
cardiac output and ability to expire and inspire appropriately for the single breath-hold 
technique (Macintyre et al., 2005). Equally, a number of factors can aect the FVC 
measurement including patient eort, ﬁtness levels and co-existent emphysema (Miller 
et al., 2005). 
In a similar study to ours, Xaubet et al (Xaubet et al., 1998) prospectively studied 39 
untreated patients with IPF who underwent HRCT and full pulmonary function tests at 
baseline. Two radiologists in consensus performed a semi-quantitative visual scoring of 
the amount of ground glass opaciﬁcation and ‘reticular patterns’ at each of 6 pre-
deﬁned anatomical levels. They did not specify quantiﬁcation of honeycombing and 
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therefore it is assumed that this was included within the reticular pattern. Scoring was 
performed to the nearest 10% and then scores at the six levels were averaged to give a 
single overall score - the ‘global disease extent’. The same method was employed to 
quantify emphysema. In 34 of the patients there was both ground glass opaciﬁcation 
and a reticular pattern and in 30 of these cases, the reticular pattern was greater in 
extent that the ground glass opaciﬁcation. They found that there was a signiﬁcant 
correlation between global disease extent and both DLCO (R = -0.40, p = 0.03) and FVC 
(R = -0.46, p = 0.003). They found that patients with co-existent emphysema had a 
signiﬁcantly higher FVC but that this did not have a signiﬁcant eect on DLCO. The fact 
that we have used a volumetric measure of ﬁbrotic lung and that we have used a 
continuous scale rather than measuring to the nearest 10% may explain the greater 
correlation we saw in our study. An earlier study by Staples et al (Staples et al., 1987) 
also used a visual assessment of overall disease extent estimated to the nearest 10% and 
compared this with spirometric lung volumes and DLCO. They did not ﬁnd any signiﬁcant 
correlation between CT score and TLC, FVC or FEV1 but did ﬁnd a signiﬁcant correlation 
with DLCO (R = - 0.64, p < 0.001). More recently, a number of studies using 
computerised methods of quantifying ILD have correlated their computer scoring with 
pulmonary function tests. For example, Yoon et al assessed the scans of 71 UIP and 18 
NSIP patients with their AQS (automated quantiﬁcation score) which examines multiple 
textural features. They studied 2 interval CTs performed one year apart. They found that 
baseline ‘ﬁbrosis score’, deﬁned as honeycombing plus reticulation, had a moderate 
correlation with DLCO (R = -0.47, p < 0.05) and ‘total abnormal’ (which also included 
ground glass opaciﬁcation, emphysema and consolidation) also showed a moderate 
correlation with DLCO (R = -0.52, p < 0.05). This correlation is slightly less strong than in 
our study and there are several potential reasons for this, including patient related 
factors and factors to do with the software algorithm. However, the fact that the AQS was 
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not trained on patients with pulmonary ﬁbrosis may be particularly relevant. 
Interestingly, although their study reports correlations of change in FVC with change in 
AQS, they do not report correlation between the AQS score at baseline and baseline FVC, 
as they do with DLCO. The reason for this is not speciﬁed. A separate study by Bartholmai 
et al (Bartholmai et al., 2013) described the use of the CALIPER software for CT 
quantiﬁcation, an algorithm which uses a histogram signature mapping technique and 
multidimensional scaling (see also Section 6.2). The software was designed to measure 
honeycombing, reticulation, ground glass opaciﬁcation and emphysema. They studied a 
group of 119 subjects from the Lung Tissue Research Consortium (LTRC) which is a 
multi-institutional database of CT scans, lung function and pathology information. The 
subjects were described as having ‘interstitial lung disease’ but a speciﬁc pathological 
diagnosis was not given. Although standardised protocols are provided by the LRTC for 
GE and Siemens CT scanners, it is likely that the patients were scanned on a number of 
dierent scanners from these manufacturers. The authors found that the percentage of 
reticulation showed signiﬁcant correlation with FVC (R = -0.63) and DLCO (R = -0.65) 
and that percentage normal lung correlated with FVC (R = 0.66), DLCO (R = 0.59) and TLC 
(R = 0.56). Similar results were shown by Rosas et al (Rosas et al., 2011) in a group of 
patients with rheumatoid arthritis associated interstitial lung disease. Their texture-
based quantiﬁcation method with 25 vectors, including co-occurrence and run-length 
vectors, showed signiﬁcant correlations with FVC (R = -0.48) and DLCO (R = -0.53). In 
summary, our ﬁndings of correlation between CFS and pulmonary function tests (FVC: 
R= -0.54; DLCO: R= -0.65) are similar to those achieved in previous studies which have 
used both visual scoring methods and computerised methods. 
Ultimately, it may be that the fundamental dierences between what is being measured 
on pulmonary function tests and what is being measured on computer ﬁbrosis scores is 
such that linear correlation between the two measures with an R-value of more than 0.6 
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to 0.7 is not possible. It also raises the question of what the reference standard for 
measurement of pulmonary ﬁbrosis should be. Whilst both spirometry and DLCO provide 
functional measures of pulmonary capacity and DLCO provides an integrated assessment 
of the process of transferring carbon monoxide (and by inference oxygen) from the 
alveolus to the blood (Cotton and Graham, 2005), CT provides regional information 
about disease severity which is potentially less aected by non-respiratory impairments 
that may aect lung function tests such as general ﬁtness, musculoskeletal problems 
and haemoglobin levels. A CT scan may also be less onerous for patients than 
pulmonary function tests and can be successfully performed in patients who are unable 
to perform pulmonary function tests. 
6.4.4 Comparison of computer-estimated total ﬁbrosis, pulmonary 
function tests and the St George’s Respiratory Questionnaire
As described in the previous chapter, we found no signiﬁcant or clinically meaningful 
correlation between either the total STGRQ score or the individual domains of the STGRQ 
and either the computer ﬁbrosis score or any of the pulmonary function tests in our 
patient group. 
There are several possible reasons for this, as follows:
1) Most questionnaire studies require many more patients than we had in our study due 
to the subjective nature of this type of measurement.
2) It was noted that the mainly elderly patients in our study often had diculty with the 
three-month recall elements of the questionnaire, particularly if they had had 
intercurrent illnesses.
3) Patients have had diculty distinguishing between impairments due to respiratory 
disease and impairments due to other co-morbidities such as cardiac disease or 
musculoskeletal problems. 
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4) As previously discussed, the STGRQ was not primarily designed for patients with 
interstitial lung disease and therefore is likely to be a less good tool for quantifying IIP 
compared with quantifying the airways diseases for which it was designed. 
To our knowledge, no other studies have compared automated computerised textural 
quantiﬁcation of interstitial lung disease with quality of life questionnaires although 
Camiciottoli et al compared lung density features (MLA, kurtosis and skewness) and the 
baseline dyspnoea index (BDI) in 48 patients with systemic sclerosis associated 
interstitial lung disease (Camiciottoli et al., 2007) and found a correlation between one 
of the BDI domains (magnitude of task) and all three density features (R = -0.39 to 
-0.44; p <0.05). In a separate study on patients with systemic sclerosis, Kim et al 
described the used of their texture-based quantitative lung ﬁbrosis (‘QLF’) computer 
algorithm with radiologist scoring and with the baseline dyspnoea index. The QLF, which 
measured reticulation only, showed a small correlation with the BDI domains of 
‘magnitude of task’ (R-value = 0.16, p =0.02) and ‘magnitude of eort’ (R-value = 0.17, 
p = 0.01) (Kim et al., 2010). 
6.4.5 Radiologist agreement
We found excellent agreement between radiologists for total ﬁbrosis (ICC = 0.94) and 
honeycombing (ICC = 0.90) with lesser agreement for reticulation (ICC = 0.60). As 
discussed in the previous chapter, honeycombing is likely to be easier to score 
accurately due to its generally well-deﬁned borders, relative homogeneity and typical 
appearance. Reticulation tends to have less well-deﬁned borders and reticular 
abnormalities often interdigitate with normal appearing lung, making it dicult to 
segment manually or visually. Other studies which have compared radiologist 
agreement for measures of pulmonary ﬁbrosis include the study by Yoon et al (Yoon 
et al., 2013) which compared the scoring of 89 scans (71 UIP and 18 NSIP) by two 
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radiologists. Each radiologist scored the scans to the nearest 5% for the following 
classes: normal, emphysema, ground glass opaciﬁcation, reticular opacities, 
honeycombing and consolidation. Although not explicitly stated in the paper, it is 
assumed that all slices were scored as they used non-spiral scans which would each 
have contained only approximately 20 slices with lung parenchyma on them. They 
found ICCs of 0.63 for honeycombing and 0.49 for reticulation which were less good 
than our correlations of 0.90 for honeycombing and 0.60 for reticulation. Maldonado 
et al (Maldonado et al., 2014), in the electronic supplement to their article, quoted 
ICCs for radiologist scoring of 12 dierent anatomical zones of the lung, dividing the 
lung into upper, middle and lower zones vertically and into ‘rind’ and ‘core’ regions 
from outside to inside. They quoted ICCs for honeycombing between 0.33 and 0.72 
and for reticulation between 0.46 and 0.77 depending on the anatomical zone. 
Interestingly, there was better agreement between the radiologists for reticulation 
scores in all the rind sections compared with the corresponding core sections but 
there was no dierence between rind and core with respect to agreement on 
honeycombing. Again, the agreement between the radiologists on the Maldonado 
paper is less good than in our study although clearly our ﬁndings are limited by the 
relatively small numbers of comparison slices. 
6.4.6 Strengths and weaknesses of the study
There are several strengths to our study, as follows:
1) One of the main strengths is that the study was performed prospectively, whereas the 
majority of studies using QCT of ILD are retrospective. A potential criticism of 
retrospective studies is that only a small proportion of available scans were suitable for 
analysis with quantitative CT (QCT). For example, Maldonado et al were only able to 
identify 55 patients with at least 2 scans suitable for analysis over a 10 year period. It is 
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likely that many more patients than this were scanned but the scans were not suitable 
for analysis. The authors do not state how many scans were reviewed in order to identify 
the 55 paired scans for analysis. Issues which may make scans unsuitable for QCT 
include excessive image noise, breathing/cardiac motion, expiratory or non-spiral 
acquisition and super-added disease such as infection. Breathing artefact is a particular 
problem in patients with ILD who may often struggle to sustain a prolonged breath-
hold. This sampling bias makes it dicult to know how generalisable the QCT technique 
is and how frequently it might work on routine scans. Other studies have scanned 
patients prospectively as part of pharmaceutical trials but the CT analysis is often done 
in a post-hoc manner (Best et al., 2003, Kim et al., 2010). 
2) Another strength of our study is the spiral nature of our CT scans. Until relatively 
recently, the standard high-resolution CT protocol was a non-contiguous acquisition 
with slices obtained every 10 to 30 mm meaning that typically only 10% of the lung 
volume was scanned. Comparison of this non-volumetric technique with a global 
measure such as DLCO or FVC is inherently ﬂawed due to the sampling error produced by 
only assessing part of the lung volume with CT. Using a non-spiral technique also risks 
underestimating disease extent which is typically worse at the lung bases. The lower 
lobes may contribute most of the disease extent in terms of the total lung volume but if 
only a few lower lobe slices are obtained then their contribution may be under-
estimated. A recent study of cyclophosphamide vs placebo in scleroderma lung disease 
showed a 12% dierence between the two groups when the most severely aected parts 
of the lung were compared but only a 5% dierence when the whole lung was assessed 
(Kim et al., 2011). Even recently, studies of quantitative CT in interstitial lung disease 
have used non-spiral acquisitions (Rosas et al., 2011, Yoon et al., 2013). This likely 
reﬂects the retrospective nature of these studies which analyzed scans which had been 
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acquired before spiral CT was routinely performed in IIP but limits how generalisable 
their ﬁndings are to modern scanning techniques. 
3) As one of the beneﬁts of the prospective study design, we took great care to optimise 
the CT parameters and ensure that these were accurately reproduced for all the scans. 
All scans were performed on the same scanner, using the same research protocol with 
dedicated breathing instructions and identical reconstruction algorithms. 
4) A strength of our experimental approach was the use of the control group of normal 
scans. This informed our understanding of potential sources of error in the computer 
algorithm and the eects of varying CT acquisition parameters such as reconstruction 
algorithm and degree of inspiration. 
Our study has a number of limitations. Firstly, we did not employ spirometric control to 
ensure that all the scans were performed in a ﬁxed percentage of inspiration. It is known 
that depth of inspiration has a marked eect on lung attenuation (Newell Jr et al., 2013) 
and we have demonstrated signiﬁcant eects of depth of respiration on the 
classiﬁcation of normal lung using our texture-based method. However, whilst the use 
of spirometric gating allows more precision for determining depth of inspiration, it can 
be technically challenging for patients with lung disease (Madani et al., 2010) and is not 
routinely available in clinical practice. 
Another potential criticism of our study is that we did not use a ‘noise index’ to increase 
or decrease the mA in order to produce a target noise level. As previously discussed, this 
can cause problems with classiﬁcation of textural abnormalities, often generating false 
positive abnormalities. Whilst acknowledging this will have led to a degree of inaccuracy 
in our results, the decision to used ﬁxed exposure parameters was made in order to 
ensure that there was a more consistent range of dose to our research patients, who 
may not directly beneﬁt personally from participation in the study. 
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We have also acknowledged the fact that the training of the algorithm by a single 
radiologist and the use of a single training scan are potential limiting factors (section 
6.2). Finally we recognise that the small numbers of patients in our study limits the 
conclusions which can be drawn. 
6.5 CONCLUSION
In summary, we have developed and tested a novel computer algorithm based on 
Minkowski functionals for the analysis of lung texture on CT scans of the thorax. Testing 
of the algorithm on normal scans and a group of prospectively recruited patients with 
pulmonary ﬁbrosis has shown that, despite some minor limitations, the algorithm can 
successful segment the ﬁbrotic lung from the surrounding tissues and separate it into 
the main types of ﬁbrosis normally assessed by radiologists. A moderate correlation was 
shown between the radiologist and computer scoring, which was comparable with 
previous studies. Signiﬁcant correlations were also shown between the computer 
estimated ﬁbrosis score and the pulmonary function tests DLCO and FVC. Our study is 
the ﬁrst prospective study to use Minkowski functionals for the assessment of 
pulmonary ﬁbrosis and the standardised nature of our CT protocol and relative lack of 
selection bias makes our results likely to be more robust than similar retrospective 
studies. We also showed that training of the algorithm improved its performance. We 
believe that our computer algorithm has the potential for assessing severity of chronic 
ﬁbrosing interstitial lung disease on individual scans as well as the potential for 
assessing change in lung disease with time. 
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CHAPTER 7: FUTURE DIRECTIONS
7.1 INTRODUCTION
Having demonstrated initial promising results with our new computer algorithm for the 
assessment of CFIP, there are several areas that need further work and several potential 
future applications for the algorithm. We will now discuss potential future work, 
concentration on improving the computer algorithm, testing of the algorithm in larger 
patient numbers, analysis of serial scans, potential use as a predictive classiﬁer or 
surrogate endpoint and use in other lung pathologies. 
7.2 DEVELOPING THE COMPUTER ALGORITHM
We have already highlighted a number of areas where the computer algorithm could be 
improved and these can be summarised as follows:
1) We would like to try and reduce or eliminate the edge artefact which is seen at the 
surface of the lung and erroneously increases the percentage of honeycomb or 
reticulation classiﬁcations. Several methods could be used to overcome this including 
using overlapping VOIs at the edge of the lung to increase the amount of sampling in 
this area and reduce any partial volume eect. Another approach is to ‘reﬂect’ or 
‘project’ the outer rind of the lung outside the lung surface so that this lung is no longer 
seen by the algorithm as being at the edge. The excess projected lung could then be 
trimmed by the algorithm following the classiﬁcation step. 
2) We would like to improve the removal of more distal airways and blood vessels from 
the lung volume since these can be erroneously classiﬁed as ﬁbrosis. There are several 
dierent potential methods for removing these structures and several dierent methods 
may need to be tested before ﬁnding the most successful method. Challenges to 
improving this aspect of the algorithm include whether/how to ‘ﬁll’ the holes left by 
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small vessels and avoiding removal of lung parenchyma during the segmentation 
process. 
3) It would be beneﬁcial to train the algorithm to detect other pathological textures such 
as emphysema or ground glass opaciﬁcation. This would need an appropriately selected 
training set of scans with these abnormalities and appropriate radiologist mark-up.
4) We believe the accuracy of the computer algorithm could be improved by training on a 
larger number of scans from patients with CFIP with a wider range of disease severity 
and by training the algorithm with larger numbers of radiologists. 
7.3 TESTING OF THE COMPUTER ALGORITHM IN LARGER NUMBERS OF PATIENTS
We have already acknowledged that we have tested the algorithm in a relatively small 
number of patients. Although it is encouraging that we have shown statistically 
signiﬁcant agreement between the output of the computer algorithm and radiologist 
visual scoring and signiﬁcant correlations with pulmonary function tests, we recognise 
that validation of the software in a larger patient group is necessary. We plan to do this 
in the near future. 
7.4 TESTING THE ALGORITHM ON SERIAL SCANS
We also plan to test the algorithm on serial CTs performed at deﬁned intervals in order 
to see how well the algorithm can quantify change in disease and whether it is more 
sensitive to change than pulmonary function tests or patient questionnaires. These 
patients have already been recruited into the QUIC study and we expect the data will be 
available for analysis in 2016. 
If we can show that the algorithm is able to detect change in disease over time, there is  
potential for it to be used in the future as a surrogate endpoint for clinical trials of 
therapeutic agents. However, ultimate validation of the algorithm for this purpose is 
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likely to need a multi-centre study with sucient patients in mild, moderate and severe 
groups and a follow-up period long enough to reach deﬁned endpoints of either 
mortality or a signiﬁcant change in lung function. In future studies we would also 
consider amending the CT protocol to use an automated mA modulation with a ﬁxed 
noise level in order to ensure consistent image noise in all patients. 
7.5 USE OF THE ALGORITHM FOR ASSESSMENT OF OTHER LUNG PATHOLOGIES
With appropriate training, we believe the algorithm could be adapted for use in other 
lung pathologies. The most obvious examples would be other ﬁbrotic lung disease such 
as scleroderma lung disease or rheumatoid associated lung disease. There is also 
potential for use in other lung diseases which cause distortion of the normal lung 
architecture and scarring such as sarcoidosis. 
7.6 CONCLUSION
We believe that further technical improvement/training of the computer algorithm 
would improve its performance and that it has potential for use as a surrogate endpoint 
or predictive biomarker if it’s validity can be proved in a large, longitudinal, prospective 
study. We also believe that textural analysis of the lung using algorithms such as ours 
has future use in several other lung diseases which aect the lung parenchyma. 
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APPENDICES
APPENDIX A: CASE RECORD FORM
NB: pages 8-16 of the CRF have not been reproduced as they relate to later study visits 
and this thesis deals only with the ﬁrst (baseline) visit. 
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APPENDIX B: ST GEORGE’S RESPIRATORY QUESTIONNAIRE (STGRQ)
St George’s Respiratory Questionnaire - ﬁrst page
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St George’s Respiratory Questionnaire - second page
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St George’s Respiratory Questionnaire - third page
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St George’s Respiratory Questionnaire - sixth page
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